Professional Documents
Culture Documents
Guide
February 2017
For Private Circulation only
www.sharekhan.com
More good,
less bad and
nothing ugly
Registered Office: Sharekhan Limited, 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station,
Kanjurmarg (East), Mumbai 400042, Maharashtra. Tel: 022 - 61150000. Sharekhan Ltd.: SEBI Regn. Nos.: BSE: INB/INF011073351 / BSE-
CD; NSE: INB/INF/INE231073330 ; MSEI: INB/INF261073333 / INE261073330 ; DP: NSDL-IN-DP-NSDL-233-2003 ; CDSL-IN-DP-CDSL-271-2004;
PMS-INP000000662 ; Mutual Fund-ARN 20669 ; For any complaints email at igc@sharekhan.com ; Disclaimer: Client should read the Risk
Disclosure Document issued by SEBI & relevant exchanges and the T & C on www.sharekhan.com before investing.
DISCLAIMER: This document has been prepared by Sharekhan Ltd. (SHAREKHAN) and is intended for use only by the person or entity to which it is addressed to. This Document may contain confidential and/or privileged material and is not for any type of circulation and any
review, retransmission, or any other use is strictly prohibited. This Document is subject to changes without prior notice. Kindly note that this document is based on technical analysis by studying charts of a stocks price movement and trading volume, as opposed to focusing
on a companys fundamentals and as such, may not match with a report on a companys fundamentals.(Technical specific) This document does not constitute an offer to sell or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any
transaction. Though disseminated to all customers who are due to receive the same, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is obtained from publicly available data or other sources believed to be reliable and SHAREKHAN has not independently verified the accuracy and completeness of the said data and hence it should not be relied upon as such. While we would
disclaimer
endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (SHAREKHAN and affiliates) are under no obligation to update or keep the information current. Also, there may be
regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. This document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Recipients of this report should also
be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems
necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment
discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. AffiliaDisclaimer
This document has been prepared by Sharekhan Ltd. (SHAREKHAN) and is intended for use only by the person or entity to which it is addressed to. This Document may contain confidential and/or privileged material and is not for any type of circulation and any review, retrans-
mission, or any other use is strictly prohibited. This Document is subject to changes without prior notice. Kindly note that this document is based on technical analysis by studying charts of a stocks price movement and trading volume, as opposed to focusing on a companys
fundamentals and as such, may not match with a report on a companys fundamentals.(Technical specific) This document does not constitute an offer to sell or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Though
disseminated to all customers who are due to receive the same, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is obtained from publicly available data or other sources believed to be reliable and SHAREKHAN has not independently verified the accuracy and completeness of the said data and hence it should not be relied upon as such. While we would en-
deavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (SHAREKHAN and affiliates) are under no obligation to update or keep the information current. Also, there may be regulatory,
compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. This document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Recipients of this report should also be aware
that past performance is not necessarily a guide to future performance and value of investments can go down as well. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary
to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or
views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which
would subject SHAREKHAN and affiliates to any registration or licencing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document
may come are required to inform themselves of and to observe such restriction.
The analyst certifies that the analyst has not dealt or traded directly or indirectly in securities of the company and that all of the views expressed in this document accurately reflect his or her personal views about the subject company or companies and its or their securities and do
not necessarily reflect those of SHAREKHAN. The analyst further certifies that neither he nor his relatives has any direct or indirect financial interest nor have actual or beneficial ownership of 1% or more in the securities of the company nor have any material conflict of interest
nor has served as officer, director or employee or engaged in market making activity of the company. Further, the analyst has also not been a part of the team which has managed or co-managed the public offerings of the company and no part of the analysts compensation was,
is or will be, directly or indirectly related to specific recommendations or views expressed in this document.
Either SHAREKHAN or its affiliates or its directors or employees / representatives / clients or their relatives may have position(s), make market, act as principal or engage in transactions of purchase or sell of securities, from time to time or may be materially interested in any of
the securities or related securities referred to in this report and they may have used the information set forth herein before publication. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without
limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind.
Compliance Officer: Ms. Namita Amod Godbole; Tel: 022-6115000;
For any queries or grievances kindly email igc@sharekhan.com or contact: myaccount@sharekhan.com tes of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which
would subject SHAREKHAN and affiliates to any registration or licencing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document
may come are required to inform themselves of and to observe such restriction.
The analyst certifies that the analyst has not dealt or traded directly or indirectly in securities of the company and that all of the views expressed in this document accurately reflect his or her personal views about the subject company or companies and its or their securities and do
not necessarily reflect those of SHAREKHAN. The analyst further certifies that neither he nor his relatives has any direct or indirect financial interest nor have actual or beneficial ownership of 1% or more in the securities of the company nor have any material conflict of interest
nor has served as officer, director or employee or engaged in market making activity of the company. Further, the analyst has also not been a part of the team which has managed or co-managed the public offerings of the company and no part of the analysts compensation was,
is or will be, directly or indirectly related to specific recommendations or views expressed in this document.
February 2017 3 Sharekhan ValueGuide
Either SHAREKHAN or its affiliates or its directors or employees / representatives / clients or their relatives may have position(s), make market, act as principal or engage in transactions of purchase or sell of securities, from time to time or may be materially interested in any of
the securities or related securities referred to in this report and they may have used the information set forth herein before publication. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without
limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind.
Compliance Officer: Ms. Namita Amod Godbole; Tel: 022-6115000; For any queries or grievances kindly email igc@sharekhan.com or contact: myaccount@sharekhan.com
REPORT CARD EQUITY FUNDAMENTALS
The first of the major domestic macro-economic events - the Union Budget - is behind us.
It neither disappointed nor delighted the markets. The finance minister has stuck to basics
with focus on increasing capital expenditure allocation while maintaining fiscal prudence.
The Budget for FY2018 aims to stimulate the Indian economy through healthy allocation
towards Housing, Agriculture and Rural sectors, besides infrastructure development. At the
same time, the Budget projects to limit the fiscal deficit at 3.2% of GDP. The net market
borrowings at Rs3.48 trillion for FY2018 is lower than market expectations of ~Rs4.2 trillion.
Further, no bad news on the long-term capital gains tax (LTCG) in equities is good news
for investors. Overall, the Budget is positive for the Indian economy in general and equity
markets in particular
Separately, the RBI has kept the Repo Rate unchanged at 6.25% while also changing its
policy stance to Neutral from Accommodative. This means the probability of incremental
rate cuts by the RBI has reduced considerably now. The central bank is concerned about
the possible supply side disruption due to demonetisation and inflationary pressure arising
from the spike in the crude oil prices. However, the focus of the Union budget on reviving
growth without compromising on fiscal prudence should bode well for limiting upside risks
to inflation.
Meanwhile, demonetisation led to a sudden disruption in the Indian economy in late 2016,
with consumer demand hit badly. As a result, FY2017 is likely to end as a disappointing year
for growth in corporate earnings. Commodity prices (including crude oil) too have started
rising and would further hurt the profitability of India Inc, besides affecting government
finances.
If that wasnt enough, the global environment remains uncertain. The global financial
markets would take some more time to adjust to the new normal of changing monetary
policy stance by the Federal Reserve, and the unpredictable policy of the Donald Trump
regime.
While the global economic scenario is expected to improve only gradually, the adverse
impact of demonetisation and other anti-black money measures should recede in a couple
of quarters.
The weakness in Q3 and Q4 of FY2017 could reverse by Q1FY2018 and corporate earnings
should grow in double digits by H2FY2018, owing to a low base and recovery in the Indian
economy. Moreover, the valuations (reasonable post demonetisation) would turn more
favorable over the next couple of quarters.
The benchmark Indian equity indices are likely to remain volatile in the near term due to
uncertainty over remonetisation, outcome of the crucial UP state elections and the pace of
the domestic economic recovery. We believe that investors should use the current volatility
to systematically buy quality stocks over the next few months, as the outlook for the Indian
equities remains constructive for the medium term (12-24 months). Follow our model
portfolios and/or advisory products to build a quality portfolio.
ABSOLUTE RETURNS (TOP PICKS VS BENCHMARK INDICES) (%) CONSTANTLY BEATING NIFTY AND SENSEX (CUMULATIVE RETURNS SINCE
Sharekhan Sensex Nifty CNX APRIL 2009)
(Top Picks) Midcap
700
100
YTD CY2017 8.4 3.9 4.6 7.4 600
Nov-13
Nov-14
Jun-11
Jan-12
Jun-15
Jan-16
Jan-17
Jul-09
Jul-10
Jul-14
May-12
May-16
Mar-10
Feb-11
Mar-14
Feb-15
Apr-09
Oct-10
Apr-13
Oct-15
Sep-11
Sep-12
Dec-12
Aug-13
Sep-16
CY2010 16.8 11.5 12.9 11.5
CY2009 116.1 76.1 72.0 114.0
Please note the returns are based on the assumption that at the beginning of each month an equal amount was invested in each stock of the Top Picks basket
Remarks: Balrampur Chini Mills (BCML) is one of the largest sugar mills in India with sugarcane crushing capacity located in the second
highest sugar producing state in India - Uttar Pradesh. The company has sugarcane crushing capacity of 76,500 tonne per day
(TCD). It also has Distillery and Co-generation operations of 320 KLPD and 148.2 MW (saleable), respectively.
he Indian sugar companies are in a sweet spot, as sugar prices have firmed up to Rs35-36 per kg in the domestic market
T
(from the lows of Rs20 per kg in July 2015) due to a demand-supply mismatch in the international market. The domestic sugar
production is expected to be down 10% YoY in sugar year (SY) 2015-16 and is expected to dip further in SY 2016-17. The upsurge
in the domestic sugar prices is positive for large sugar companies such as BCML with large production capacity, better leverage
position and strong relationships with cane farmers.
CMLs leverage position is much better in the domestic sugar industry compared to some of the other UP- based sugar companies,
B
such as Dhampur Sugar (1.2x as on September 30, 2016). The company is confident of funding the capex of Rs100 crore and repay
the debt of around Rs150 crore in FY2017 on the back of expected improvement in the cash flows.
ny significant increase in the global sugar production (resulting in a drop in sugar prices) or a decline in the sugar recovery rate
A
would act as a key risk to the earnings.
CML stock is trading at 8.5x its FY2017E earnings and 9.8x its FY2018E earnings, which is much lower than the 18-20x multiple
B
it commanded in the last sugar up-cycle of sugar season 2008-10. We have a positive view on the stock.
BHARAT ELECTRONICS 1,540 27.1 21.8 20.2 15.5 14.0 13.2 1,770 15
Remarks: Bharat Electronics (BEL), a PSU manufacturing electronic, communication and defence equipment, stands to benefit from the
enhanced budgetary outlay for strengthening and modernising the countrys security.
he Make in India initiative of the NDA government, along with greater thrust to modernise the countrys defence equipment
T
will support the earnings growth in the coming years, as it is the only player with strong research and manufacturing capabilities
across the country.
he companys current order book of ~Rs33,806 crore provides revenue visibility for the next 3-4 years. We expect the companys
T
revenue to grow at a CAGR of 14% over FY2016-FY2019E, led by strong order wins and impressive execution rate.
EL remains our preferred pick in the defense sector on account of its strong manufacturing and R&D base, good cost control
B
and growing indigenisation.
GLENMARK PHARMA 893 23.6 17.4 15.5 25.0 25.7 22.7 1,150 29
Remarks: Glenmark Pharmaceuticals is a research-driven global pharmaceuticals organization, focused on discovering novel molecules
and developing high-quality generics & specialty products for markets across the globe. Glenmark has 17 manufacturing facilities
across five countries, including the US, Switzerland, Argentina, Czech Republic and India. Glenmark has five R&D Centres around
the world engaged in discovery of novel biological and chemical entities.
he management has indicated that for future growth, the key focus areas will be Dermatology, Contraceptives and Complex
T
Injectables. The future growth would be mainly propelled by US, EU and India markets, which are witnessing exponential growth
on account of new product launches. The company is gearing up for the launch of gZetia, where it has 180-day exclusivity in the
US (launch in H2FY2017). Also, there are few more significant opportunities, which fall in FY2018.
lenmark is in the process of aggressively ramping up products in the US, India and EU markets, which should give a major boost
G
in the next couple of years. The gZetia launch scheduled in H2FY2017 will give a big fillip to the companys sales and profitability,
which should further help reduce debt. We have a positive outlook on Glenmark and recommend a Buy.
GRASIM INDUSTRIES 911 17.5 13.0 11.1 9.4 11.0 11.2 1,150 26
Remarks: Grasim Industries, a flagship company of the Aditya Birla Group ranks among Indias largest private sector companies having core
businesses of Cement (~70% of revenue with listed subsidiary UltraTech Cement), Viscose Stable Fibre (~20%) and Chemicals
(~10%). The company has benefitted from improvement in its profitability in all of its three divisions with outlook continuing to
be positive.
he timely acquisition of JP Groups cement assets, continuous brownfield expansions and de-bottlenecking are likely to
T
increase its cement capacity to over 90MT. The structural growth triggers like rising infrastructure investment and pick-up in
rural demand (owing to a good monsoon) are likely to help sustain a favourable growth outlook for the cement sector. The revival
in VSF prices, absence of major capacity additions in China, low inventory and leverage of LIVA brand are likely to sustain VSF
divisions profitability going forward. Further, the company will expand its Caustic Soda capacity from 840KTPA to 1048KTPA in
FY2018, which should sustain its volume growth.
he current restructuring exercise of aligning high-growth businesses in Manufacturing (Cement, Textiles, Chemicals, Insulators,
T
Solar etc) and Services (Financial Services & Telecom post approval of proposed group restructuring scheme) provides a unique
opportunity to investors to hold a well-diversified portfolio, which is expected to maintain strong growth momentum going
forward across verticals. Overall, we expect Grasim Industries to reap benefits going forward, considering the revival in its core
VSF division, strong demand and better realisations in Chemicals and sturdy growth outlook for the Cement business.
HDFC BANK 1,287 26.5 22.3 18.5 18.3 18.7 19.4 1,500 17
Remarks: HDFC Bank has a pre-eminent presence in the retail banking segment (~50% of loan book) and has been able to maintain a
strong & consistent loan book growth, gradually gaining market share. Going forward, economic recovery and improvement in
consumer sentiment would be positive growth drivers for the banks loan growth, which will in turn drive its profitability.
Backed by a current account & savings account (CASA) ratio of 40%+ and a high proportion of retail deposits, the banks cost of
funds remains among the lowest in the system, helping it to maintain higher net interest margin (NIM). In addition, the banks
loan book growth is driven by high-yielding retail products such as personal loans, vehicle loans, credit cards, mortgages etc,
mostly to own customers (which also positively impacts NIMs).
HDFC Bank has been maintaining near impeccable asset quality, with its NPA ratios consistently been among the lowest versus
comparable peers. The bank has been able to maintain a robust asset quality due to its stringent credit appraisal procedures
and negligible exposure to troubled sectors.
HDFC Bank is well poised to tap the growth opportunities going ahead due to strong capital ratios, healthy asset quality and
steady revival in consumer spending. Recent demonetisation would help the bank to gain more deposits. Also, as lending and
transactions through formal routes increase, HDFC Bank would benefit since it is a leading private sector bank and it is likely that
it will gain market share in this segment. The bank is likely to maintain a healthy RoE of 18-20% and RoA of 1.8% on a sustainable
basis. Therefore, we expect it to sustain the valuation premium that it enjoys vis--vis other private banks.
INDIAN OIL CORP 366 13.4 12.1 10.3 18.4 18.1 18.7 405 11
Remarks: Indian Oil Corporation (IOC) is a leader in the domestic downstream oil sector with non-replicable infrastructure total refining
capacity of 80.7 mmt (35% market share), retail outlets of 25,363 (45% market share) and pipeline capacity of 80.6 mmt (market
share of 55% among downstream companies). The company is also a market leader in the domestic petroleum sales with volume
of 72.7 mmt (45.9% market share) in FY2016.
We expect IOCs EPS to grow by 10%/17% in FY2017/FY2018, led by ~6-7% growth in domestic consumption of HSD/MS,
recovery in refining margins (Singapore complex GRM has improved sharply to around $6.7/bbl in Q3FY2017 so far vs $5.1/bbl in
Q2FY2017), stabilisation of the 15-mmt Paradip refinery (expected to operate at 90% utilisation by February 2017) and inventory
gains (given our expectation of stable-to-rising oil prices). The Paradip refinery could add Rs3-4/share to FY2018E EPS at GRM of
$9-10/bbl.
The company is also implementing pipeline expansion projects at an estimated capex of Rs12,000 crore over the next couple of
years, which would add 22 mmt to IOCs pipeline capacity.
IOC has a strong balance sheet, with low net debt-to-equity ratio (D/E) of 0.64x in FY2016 and we expect RoE to expand to 18.7%
in FY2018 (vs 18.4% in FY2016).
INDUSIND BANK 1,253 32.6 25.2 19.2 16.1 16.7 17.6 1,394 11
Remarks: IndusInd Bank is among the fastest growing banks (26% CAGR over FY2012-FY2016), with a loan book of Rs93,678 crore and 1,000
branches across the country. About 55% of the banks loan book comprises of retail finance, which is a high-yielding category,
and is showing signs of growth.
Given the aggressive measures taken by the management, the deposit profile has improved considerably (CASA ratio of ~35%).
Going ahead, the bank would follow a differentiated branch expansion strategy (5% branch market share in identified centers)
to help in ensuring healthy growth in savings accounts and retail deposits.
IndusInd Bank has maintained its asset quality despite sluggish economic growth and higher proportion of retail finance in its
loan book. The banks asset quality is among the best in the industry, with total stressed loans (restructured loans + gross NPAs)
forming less than 1.50% of the loan book.
A likely revival in the domestic economy will further fuel growth in the banks consumer finance division while strong capital
ratios will support future growth plans. Though the recent demonetisation has raised questions regarding delinquencies in
certain lending segments, the management expects asset quality to remain under control. The stock should continue to trade at
a premium valuation, underpinned by strong loan growth, quality management, high RoAs and healthy asset quality. We have a
positive outlook on IndusInd Bank.
MARUTI SUZUKI 5,896 39.0 24.0 21.8 18.6 23.1 21.6 6,430 10
Remarks: Maruti Suzuki India (Maruti) is Indias largest passenger vehicle (PV) manufacturer with a strong 47% market share. Over the last
two years, the company has been able to gain market share due to new product launches, a vast distribution network (with an
increased focus on the rural markets) and a shift in consumer preference to petrol models from diesel models.
The recently launched premium hatchback Baleno and the crossover Ignis have received a strong response, which will help
Maruti to expand its market share in the segment. The compact sports utility vehicle (SUV) Vitara Brezza has also received an
encouraging response. All the three new launches command a waiting period of 6-8 months each. Further, the recent entry in
the light commercial vehicle (LCV) segment would also boost overall volumes.
Maruti has maintained its FY2017 volume target of 1.55 million units despite the demonetisation move, as the proportion of
financing in the companys overall sales is around 80%, which is higher than the PV industry average of ~65-70%. Hence, the
impact of demonetisation on Maruti sales is likely to be relatively lower.
In FY2018, Maruti would see higher volume growth, driven by the expected resurgence in demand post demonetisation and
planned new launches. Also, the Gujarat plant is expected to commence operations in March 2017. New products and high order
backlog for the recent launches (Baleno, Brezza and Ignis) would enable Maruti to outpace the PV industry growth in FY2018.
RBL BANK 382 42.4 32.9 22.4 11.2 12.0 14.2 434 13
Remarks: RBL Bank (RBL) has been among the fastest growing private sector banks in the past 5-6 years, with advances CAGR of 61.9% over
FY2011-FY2016. Over these years, the bank had restricted its growth to a few geographies, but now it is focusing on expanding
into newer locations.
espite a high growth trajectory, RBL has managed to maintain a strong asset quality over the years. As of March 2016, RBLs
D
GNPA stood at 0.98%, which was among the best in the banking industry. The bank mostly lends working capital loans to large
and medium corporates, which are short-term in nature and less risky.
S ince 2010, RBL has seen a business transformation under the new management team spearheaded by Vishwavir Ahuja (current
MD & CEO). He has over 35 years of experience in the banking industry and was also the Managing Director in Bank of America
for their India business.
BL has invested and worked towards significantly improving and upgrading its processes, risk management systems, digital
R
technology, branch expansion and human capital. As a result, the banks operations are better calibrated now, and should start
showing results in terms of improved return ratios and a stable asset quality going forward.
SUPREME INDUSTRIES 937 56.1 32.9 24.9 16.1 22.9 24.9 1,067 14
Remarks: Supreme Industries is a leading manufacturer of plastic products with a significant presence across Piping, Packaging, Industrial
and Consumer segments.
S upreme Industries has emerged as one of the best proxy plays on the growing plastic consumption in India on the back of a
diversified product portfolio, an extensive distribution network, improved capital structure and government thrust on building
a better infrastructure.
he management is continuously focusing on high-value product segments, which now contribute close to 37% to the total
T
revenue [introduced new value-added products in Sipaulin (management does not see any threat from competitors in this space
as the company enjoys strong margins of 20-23%). For the next 2-3 years, the management expects 12-14% volume growth
comfortably, but foresees OPM at 14-14.5% going forward from the current ~16% odd levels.
e remain positive on the introduction of value-added products and capacity expansion plans, which are largely funded by
W
robust internal accruals. Supreme Industries enjoys superior return ratios with low gearing levels, and we expect the company
to maintain high return ratios going forward. We believe that the impending GST rollout in the long run will be a boon for the
established players like Supreme Industries.
UPL LIMITED 726 21.6 20.3 16.1 19.1 22.2 22.7 855 18
Remarks: UPL is a leading global producer of crop protection products, intermediates, specialty chemicals and other industrial chemicals,
The company has presence across agricultural inputs, ranging from seeds to crop protection products and post-harvest activities.
PLs unwavering focus on the core business and the ability to introduce innovative products (both in India and overseas
U
markets), presence in high-growth markets (Brazil and India) and plans of tapping new markets are key positives for the future
growth outlook. In line with this, during Q3FY2017, UPL launched two new products (one each in the Fungicides and Herbicides
categories) in Latin American and three new products (one crop nutrient and two fungicides) in India.
S trong growth momentum in Latin America (including Brazil), with the company aiming to outpace the industry growth and gain
market share, coupled with a favorable outlook for the Indian business will help UPL to boost its overall performance going
ahead.
e expect UPLs consolidated revenue to grow at a 17% CAGR over the next two years. Benefits of operating leverage and a
W
better product mix would aid margin expansion, and we expect the OPM to expand by 100BPS between FY2017 and FY2019. We
have a Buy recommendation on the stock.
ZEE ENTERTAINMENT 490 43.7 36.8 28.6 24.4 25.4 26.8 560 14
Remarks: Among the key players in the domestic Cable TV industry, we expect the broadcasters to be the prime beneficiaries of the
mandatory digitisation process initiated by the government. The broadcasters would benefit from higher subscription revenue
at the least incremental capex, as the subscriber declaration standard improves in the Cable TV industry
ee Entertainment Enterprises (ZEEL) continues to lead the broadcasting industry in advertising revenue growth. ZEEL is one of
Z
the leading players in television broadcasting with a bouquet of 40+ TV channels across genres.
he ZEEL management stated that it is comfortable with the OPM level of ~30% and will re-invest the gains in OPM due to the
T
sale of the loss-making Sports business (likely to add 300-350BPS in FY2018) back into the business.
he recent acquisition of general entertainment TV business from the Reliance Group will help ZEEL to expand its regional
T
presence and facilitate a foray into the comedy genre in the Hindi speaking markets. The management expects to achieve
EBITDA breakeven by the time the consolidation of the acquisition is complete (H2FY2018).
he ZEEL management has increased its focus on digital, movies, and international operations to improve the content
T
monetisation. The managements intent to remain a pure play media company gives us confidence on the prudent capital
allocation going forward. We continue to see ZEEL as the prime beneficiary of the macro revival and ongoing digitisation trend.
Centrally
Non debt sponsored
Borrowing and Other
capital, 3% scheme, 10%
other expenditure, 13%
liabilities, 19%
Corporation
tax, 19% Central sector
Scheme, 11%
States share in
Non tax tax and
revenue, 10% duties, 24%
interest
payments, 18%
Income tax, 16%
Service tax, 10% Finance
commision and
transfers, 5% Defense, 9%
Customs , 9% Union Excise Subsidies, 10%
Duties, 14%
Source: India Budget, Sharekhan Research Source: India Budget, Sharekhan Research
Gross tax revenue and Tax as % of GDP Fiscal deficit movement and FD as % to GDP
17,000 12.0
5.4
13,000 11.0
5,000 4.4
9,000 10.0
3.4
5,000 9.0
Source: India Budget, Sharekhan Research Source: India Budget, Sharekhan Research
Tax and Non-tax revenue movement Gross and Net market borrowings
14,000 6,000
80.0
12,000 5,000
10,000 4,000
70.0
8,000 3,000
6,000 2,000
60.0
4,000 1,000
2,000 0 50.0
FY18BE
FY14
FY15
FY16
FY17RE
0
FY14 FY15 FY16 FY17RE FY18BE
Net tax revenues ('00 Cr) Non-tax revenues ('00 Cr) Gross debt market borrowings ('00) Net debt market borrowings ('00) net as % of gross borr
Source: India Budget, Sharekhan Research Source: India Budget, Sharekhan Research
Misses:
No cut in corporate tax: Among the many positive proposals, the Budget has fallen short on one of the key
expectations that India Inc had - a cut in the Corporate Tax. Though the government has cut the tax for smaller
companies to 25%, there is no relief for the bigger corporates.
Proposal to ban cash transactions over Rs3 lakh: The proposal to ban cash transactions over Rs3 lakhs
is positive for curbing black money, besides improving the formal banking and digital economy - thereby
providing further strength to the organised players. However, this move will impact sectors such as Branded
Jewellery and Luxury Housing among other luxury transactions.
Bank recapitalisation: The Budget has disappointed on the bank recapitalisation front. The Rs10,000 crore
allocated is less than last years allocation of around Rs25,000 crore.
In the Union Budget for FY2017-2018, the government has announced an average excise duty hike of 6% on
cigarettes, which is less than our as well as street expectation of 8-10% increase.
For ITC, the weighted average excise duty hike stands at 6%. We expect ITC to pass on the excise duty hike
through an average price increase of 6-8% in its cigarette portfolio in the coming months (ITC had recently
increased prices of some brands).
With the second consecutive year of moderate hike in the excise duty on cigarettes, we expect ITCs cigarette
volume to grow by 6-7% in FY2018 (the previous volume growth expectation was 5%). This would result in
a 2-3% increase in the earnings estimate for FY2018, while we broadly maintain our earnings estimate for
FY2019. But, any significant increase in the tax rate on cigarettes under the impending GST regime (likely
implementation in July 2017) would act as a key risk to our volume growth estimates for ITC.
The second consecutive year of moderate excise duty hike on cigarettes is positive for ITC, as its cigarette
volume is likely to improve and would further have a positive impact on the companys cash flows in the near
term. Any significant increase in the tax rate on cigarettes under the GST dispensation will remain a key
monitorable in the coming quarters. The ITC stock is currently trading at 25.5x and 22.3x its FY2018E and
FY2019E earnings. We maintain our Buy recommendation on the stock.
Cigarettes filter>
4,163.5 4,414.5 6.0 6.0%
85 mm
Sectoral analysis
Overall
Sector Key announcements Key companies to be affected
impact
Automobiles Total allocation of funds for Rural and Positive Increased rural sector allocation would boost
Agricultural & Allied sectors has increased by rural income, which in turn would have a positive
24% to Rs1,87,223 crore. rub-off on rural-focused companies such as Hero
MotoCorp Mahindra & Mahindra and Escorts.
Allocation for Highways increased to Rs64,900 Positive This will result in better road connectivity, which
crore from Rs57,976 crore. in turn will boost the Commercial Vehicle (CV)
sales. Positive for Ashok Leyland, Tata Motors and
Eicher Motors.
Agri - Inputs Total allocation for Rural and Agricultural & Positive UPL, Dhanuka Agri, PI Industries and Insecticides
Allied sectors for FY2018 has increased by 24% India
to Rs1,87,223 crore (with committed efforts of
doubling the income of farmers in five years).
Emphasis on irrigation through a Dedicated Positive Jain Irrigation and EPC Industrie.
Micro Irrigation Fund of Rs5,000 crore in
NABARD.
The customs duty on imported Liquefied Natural Positive Chambal Fertilisers, GSFC, RCF and NFL.
Gas (LNG), which is one of the key inputs for
fertiliser manufacturing cut from 5% to 2.5%.
Budget impact: Budget impact: Positive for gas utilities and downstream companies; negative for upstream PSUs
Sector view: Positive (preferred picks: RIL, IOCL and Petronet LNG)
Customs duty on LNG imports reduced to 2.5% Positive Petronet LNG, IGL, Gujarat Gas and GAIL.
from 5% currently.
No customs duty on crude oil imports. Positive IOCL, BPCL, HPCL, RIL, MRPL and Chennai
Petroleum.
No reduction in cess rate on oil. Negative ONGC, Oil India and Cairn India.
Fuel subsidy provision at Rs25,000 crore (LPG Neutral ONGC and Oil India.
- Rs16,076 crore and Kerosene - Rs8,924 crore)
for FY2018 factors in crude oil price of $55/bbl,
assuming a price hike per month of Rs0.5/litre
Oil & Gas
on Kerosene and Rs2/cylinder on LPG till April
2017.
Creation of an integrated public sector oil Positive ONGC, Oil India, IOCL, BPCL and HPCL.
major. (given the
synergies but
implementation
seems difficult)
Sectoral analysis
Overall
Sector Key announcements Key companies to be affected
impact
Budget impact: Positive
Sector view: Positive (prefered picks: IRB Infrastructure, IL&FS Transportation, L&T, Gayatri Projects and Ashoka Buildcon)
Increased total allocation for infrastructure Postive IRB Infrastructure, ITNL, L&T, Ashoka Buildcon,
development in FY2018 to Rs3,96,135 crore Gayatri Projects, Sadbhav Engineering and KNR
from Rs3,48,952 crore in BE FY2017. Construction among others.
In the road sector, budget allocation for Postive IRB Infrastructure, ITNL, L&T, Ashoka Buildcon,
highways has increased from Rs57,976 crore in Gayatri Projects, Sadbhav Engineering and KNR
BE FY2017 to Rs64,900 crore in FY2018. 2,000 Construction among others.
kms of coastal connectivity roads have been
identified for construction and development.
MAT/AMT credit is allowed to be carried forward Postive IRB Infrastructure, ITNL, L&T, Ashoka Buildcon,
up to a period of 15 years instead of 10 years Gayatri Projects, Sadbhav Engineering and KNR
at present. To take effect from April 1, 2018 Construction among others.
onwards.
A new Metro Rail Policy and act with greater Postive L&T and J Kumar Infraprojects.
private sector participation.
Infrastructure Select airports in Tier 2 cities will be taken Postive GMR Infrastructure and GVK Infraprojects.
up for operation and maintenance in the PPP
mode.
An amendment bill as part of the Arbitration Postive IRB Infrastructure, ITNL, L&T, Ashoka Buildcon,
and Conciliation Act 1996 will be introduced Gayatri Projects, Sadbhav Engineering and KNR
to streamline institutional arrangements for Construction among others.
resolution of disputes in infrastructure related
construction contracts, PPP and public utility
contracts.
Land monetisation and railway station Positive NBCC.
redevelopment - Amendment to the Airport
Authority of India Act to enable effective
monetisation of land assets. The resources so
raised will be utilised for airport upgradation.
However, 25 railway stations are expected to
be awarded for redevelopment during FY2018.
Budget impact: Positive
Sector view: Neutral
Affordable housing to be given infrastructure Positive DLF, Ashiana Housing, Godrej Properties, Century
status. Plyboards, Kajaria Ceramics, Cera Sanitaryware
and Somany Ceramics.
Under the scheme for profit-linked income tax Positive DLF, Ashiana Housing and Godrej Properties.
deduction for affordable housing, carpet area
instead of built up area of 30 sq mtr and 60 sq
mtr will be counted. 30 sq mtr to apply only in
case of municipal limits of 4 metro cities and
for the rest it will be 60 sq mt. To take effect
from April 1, 2018 onwards.
Reduction in the holding period for computing Neutral DLF, Ashiana Housing and Godrej Properties.
Real Estate long-term capital gains for transfer of
immovable property from 3 years to 2 years.
Also, the base year for indexation is proposed
to be shifted from April 1, 1981 to April 1, 2001
for all classes of assets, including immovable
property. To take effect from April 1, 2018
onwards.
To reduce the period of holding from the Positive DLF, Ashiana Housing and Godrej Properties.
existing 36 months to 24 months in case of
immovable property, being land or building or
both, to qualify as long term capital asset. To
take effect from April 1, 2018 onwards.
Sectoral analysis
Overall
Sector Key announcements Key companies to be affected
impact
Budget impact: Positive
Sector view: Positive (preferred picks: SBI, Bank of Baroda, PNB, Repco Home Finance and Gruh Finance
Banks Target for agricultural credit in FY2018 raised to Neutral Mainly PSU Banks.
Rs10 lakh crore (from Rs9 lakh crore in FY2017).
PSU Banks Rs10,000 crore for recapitalisation of banks Neutral In line with already announced Indradhanush Plan
provided in FY2018. to recapitalise PSU Banks. Promise of additional
funds to be made available (if required) is also
reiteration of earlier plan.
Banks Increased allowable provision for Non- Positive Will reduce tax liablity of banks; benefit to Axis
Performing Assets from 7.5% to 8.5%. Bank, ICICI Bank, SBI, BOB, PNB etc.
Banking & NBFC Affordable housing to be given infrastructure Positive Banks and HFCs like Repco Home Finance, Gruh
status. Finance, LIC Housing, PNB Housing etc. with low
average ticket size loans; will have lower risk
weights; refinance from NHB.
Banking & NBFC Bill to curtail the menace of illicit deposit Positive Will result in deposits (low cost) accretion for
schemes will be introduced. Banks and NBFCs.
Budget impact: Positive
Sector view: Positive (prefered picks: L&T, Finolex Cables, V-Guard, Kalpataru Power and Skipper)
Electrification - With commitment to achieve Positive L&T, Kalpataru Power & Transmission, KEC
100% village electrification by May 2018, the International and Skipper.
government has increased allocation by Rs4,814
crore for the Deendayal Upadhayaya Gram Jyoti
Yojna.
Water - To provide safe drinking water to over Positive Va Tech Wabag, ITD Cementation and Ion
28,000 arsenic and fluoride affected habitations Exchange.
in the next 4 years through the National Rural
Drinking Water Programme (NRDWP). Allocation
for the National Ganga Plan "Namami Gange"
stands at Rs2,250 crore.
Optic Fibre Cables- Allocation to the Bharatnet Positive Sterlite Technology and Finolex Cables.
project increased to Rs10,000 crore from
Rs6,000 crore, which will provide high-speed
broadband connectivity to Gram Panchayats
Capital Goods / with WiFi Hot Spots and access to digital
Power services at low tariffs.
Defence - Defence expenditure (excluding Positive L&T, BEML and Reliance Defence.
pension payout) has been provided a sum of
Rs2,74,114 crore, including Rs86,488 crore for
defence capital.
Solar - Proposal for the second phase of Solar Positive Ujjas Energy and Indosolar.
Park development for an additional 20,000
MW capacity and developing of 7,000 railway
stations with solar power in the medium term.
Reduction of BCD for fuel cell based power
generating systems from 6% to 5%.
LED - Basic customs duty & Countervailing duty Positive Crompton Greaves Consumer, Havells, Finolex
on all parts for use in the manufacture of LED Cables and Bajaj Electricals.
lights or fixtures, including LED lamps, reduced
to 5% & 6%, respectively.
Infra spending on railways - huge capital and Positive ABB, KEC International, Kalpataru power &
development expenditure for Railways at Transmission, Siemens, BEML.
Rs131,000 crore, of which Rs55,000 crore
provided by the government.
Metro Rail Policy - A new Metro Rail Policy Positive ABB, KEC International, Kalpataru Power &
Railway will be announced, with focus on innovative Transmission, Siemens and J Kumar Infra.
models of implementation and financing. This
will facilitate greater private participation and
investment in construction and operation with
increased budgetary allocation to Rs18,000
crore.
COMPARATIVE RETURNS
Particulars Returns (as on January 31, 2017)
Since inception (August 21, 2014)
Wealth Creator folio (weighted average returns) 16.1
- Large-cap (64%) 12.6
- Mid-cap (36%) 22.5
Sensex 4.9
Nifty 8.4
CNX Mid-cap 37.9
* Please note we see scope for upward revision in target price (three-year) of some of the stocks depending on the extent of economic recovery and will keep updating on the same
Bajaj Auto
Hold CMP: Rs2,838 January 31, 2017
COMPANY DETAILS
Price target: Rs3,000 Domestic market recovery to be offset by export
Market cap: Rs82,115 cr weakness; maintain Hold with revised PT of Rs3,000
52-week high/low: Rs3,122/2,173
NSE volume (No of shares): 2.5 lakh KEY POINTS
BSE code: 532977 Operating performance marginally ahead of estimate: Bajaj Autos (BAL) topline in
NSE code: BAJAJ-AUTO Q3FY2017 declined by 9% YoY to Rs5,067 crore, driven by an 11% drop in volumes. However,
Sharekhan code: BAJAJ-AUTO BAL surprised positively by reporting a marginal 2% YoY growth in realization. OPM declined
Free float (No of shares): 14.7 cr by 40BPS YoY to 20.6%. EBITDA at Rs1,044 crore declined by 11% YoY, but was ahead of our
SHAREHOLDING PATTERN expectation of Rs989 crore. Higher other income of Rs319 crore (up 32% YoY) led to the net
Institutions profit of Rs925 crore, which was ahead of our expectation of Rs829 crore.
Corporate
9%
Bodies
7% O
utlook for exports to remain challenging in near term: BALs key export markets have
been under pressure, as their local currencies have depreciated sharply vis-a-vis the US
Promoters Foreign dollar. BALs export volumes are down by 22% YoY in 9MFY2017 and we expect the company
49% 18%
to end FY2017 with an overall 19% drop in export volumes. BAL has indicated that the
Public and overseas headwinds are likely to persist at least for another couple of quarters.
Others
17% O
utlook and valuation: Domestic volumes are likely to recover in FY2018 on the back
of the improved liquidity situation, perked-up rural sentiment (on the back of enhanced
PRICE PERFORMANCE Rabi sowing and higher MSPs). We expect BAL to report double-digit volume growth in the
(%) 1m 3m 6m 12m domestic market. However, export volumes are likely to remain under pressure in the near
Absolute 8.8 1.7 5.5 25.4 term due to a steep fall in local currencies of BALs key export markets (Africa and Latin
Relative to Sensex 2.3 3.1 6.6 9.2 America), and heightened competition from peers. We retain our Hold rating on the stock
with a revised price target of Rs3,000.
Sharekhan Limited, its analyst or dependant(s) of the analyst might be
holding or having a postition in the companies mentioned in the article. For detailed report, please visit the Research section of our website, sharekhan.com.
Bharat Electronics
Hold CMP: Rs1,586 January 30, 2017
COMPANY DETAILS
Price target: Rs1,700
Strong performance, limited upside; downgrade
Market cap: Rs35,429 cr to Hold with revised price target of Rs1,700
52-week high/low: Rs1,624/1,009
NSE volume (No of shares): 3.5 lakh KEY POINTS
BSE code: 500049 Strong quarter: Revenue for Q3FY2017 grew by 37% YoY to Rs2,191.3 crore, led by improved
order execution. Key orders executed during the quarter included Radio Relay Frequency
NSE code: BEL
(LB), Hand Held Thermal Imager (with laser range finder), Fire Control Systems, Akash
Sharekhan code: BEL Weapon Systems (Army), 3D Tactical Control Radar, L-70 Gun upgrade and Weapon Location
Free float (No of shares): 5.7 cr Radar.
SHAREHOLDING PATTERN Margin performance continues to surprise positively: The Operating Profit Margin (OPM)
improved by 470BPS to 22%, with better operating leverage. Net profit grew by 33.3% YoY
Institutions
16% to Rs373.5 crore. At the end of Q3FY2017, total order book stood at Rs33,806 crore, up by a
Non- modest 5% YoY, which is the slowest growth in the order book in the last three quarters
promoter
Promoters corporate Likely to surpass management guidance of 10-12% topline growth in FY2017: The BEL
74% 3% management had earlier given a guidance of 10-12% revenue growth in FY2017. Given
Foreign the 9MFY2017 revenue growth (ex-other operating income) of 14% YoY, and Q4 being a
4%
seasonally strong quarter, we foresee the company overshooting the managements earlier
Public and
Others guided growth rate of 12-14%.
3%
Downgrade to Hold with a revised price target of Rs1,700: We have marginally tweaked our
PRICE PERFORMANCE earnings estimates for FY2017/FY2018 to factor in the better-than-expected performance in
Q3FY2017. BEL remains our preferred pick for the domestic defence play on account of its
(%) 1m 3m 6m 12m strong manufacturing and R&D base, good cost control and growing indigenisation to aid 14%
Absolute 9.4 19.4 23.2 27.0 CAGR in earnings over FY2016-FY2019. However, given the strong run-up in the stock of ~25%
Relative to Sensex 2.8 21.0 24.5 10.6 in the last three months (15% in the last one month alone), we see limited upside from the
current level. Therefore, we downgrade the stock to Hold from Buy with a revised price
target of Rs1,700.
Sharekhan Limited, its analyst or dependant(s) of the analyst might be
holding or having a postition in the companies mentioned in the article. For detailed report, please visit the Research section of our website, sharekhan.com.
Bharti Airtel
Hold CMP: Rs312 January 25, 2017
COMPANY DETAILS
Price target: Rs340
Competitive intensity flaring up; maintain Hold
Market cap: Rs124,539 cr
KEY POINTS
52-week high/low: Rs384/282
India wireless business feels the heat from JIO entry: Bhartis revenue declined by 3.1%
NSE volume (No of shares): 31.8 lakh
YoY and 5.3% QoQ to Rs23,364 crore, below our expectations. OPM for Q3FY2017 contracted
BSE code: 532454
by 192BPS QoQ to 36.4%, but improved by 136BPS YoY. As a result, the adjusted net profit
NSE code: BHARTI declined by 51.8% QoQ and 51.5% YoY to Rs707.7 crore.
Sharekhan code: BHARTI
C
onsolidation to gather further steam: Owing to JIOs free trial offer, the Bharti
Free float (No of shares): 131.4 cr
management believes that the competitive intensity among the nine Indian telecom players
SHAREHOLDING PATTERN will remain elevated. It also believes that the pressure will continue on data as well as voice
Institutions pricing till the JIOs free offer period is over. Since the end period of JIOs free offer is still
11%
unclear at this point, aggressive tariff plans, huge capex spends and increase in costs will
continue for the next few quarters. Large telecom players will invest to improve the quality
Foreign
of their networks and start offering aggressive tariff plans to retain or marginally increase
Promoters
67% 20% their market share. On the other hand, smaller players will struggle to compete and start
Public and
monetising their under-utilised spectrum assets. Going ahead, we believe there will be an
Others increase in M&A activity, as the smaller telcos will find it difficult to operate in the ongoing
2%
highly competitive environment and cut-throat price war.
PRICE PERFORMANCE V
aluation - Maintain Hold with a revised price target of Rs340: We have tweaked our
(%) 1m 3m 6m 12m estimates for FY2017/FY2018 on account of lower-than-anticipated performance in
Q3FY2017 and extended freebies from JIO. We are positive on Bharti in the long term due to
Absolute 7.1 3.2 -13.5 6.4
the companys largest market share in terms of revenue as well as subscribers, along with
Relative to Sensex 1.9 6.2 -12.5 -6.4
its pan-India presence and strong balance sheet strength to weather competitive intensity.
We have maintained our Hold rating on Bharti with a revised price target of Rs340.
Sharekhan Limited, its analyst or dependant(s) of the analyst might be
holding or having a postition in the companies mentioned in the article. For detailed report, please visit the Research section of our website, sharekhan.com.
Grasim Industries
Buy CMP: Rs970 January 30, 2017
COMPANY DETAILS
Price target: Rs1,150
VSF continues to outperform; Retain Buy with
Market cap: Rs45,287 cr unchanged price target of Rs1,150
52-week high/low: Rs1,070/648
NSE volume (No of shares): 5.4 lakh KEY POINTS
BSE code: 500300 VSF segment boosts earnings amid flattish cement performance: Grasim Industries
NSE code: Grasim (Grasim) consolidated net sales (net of excise duty) growth of 1.1% YoY at Rs8,495 crore
Sharekhan code: Grasim was muted, as revenue growth in VSF (up 9.8% YoY) and Chemical (up 6.3% YoY) segments
Free float (No of shares): 32.1 cr was largely offset by a 1.5% YoY drop in Cement revenue. VSF EBITDA margin expanded by
SHAREHOLDING PATTERN 359BPS due to better realisations and operating efficiencies, leading to a 6.6% YoY growth
in EBITDA. Further, the PAT grew by 13.7% YoY to Rs728 crore, led by margin expansion,
Public & others Promoter higher other income (up 14.5% YoY), lower interest cost (down 14.2% YoY) and reduced
27% 31% depreciation charge (down 3.7% YoY).
C
hemical division expansion on track; Restructuring to conclude by H1FY2018: The
merger of AB Nuvo, and the subsequent demerger and listing of the Financial Services
business have received approvals from the stock exchanges and the Competition Commission
MF & FI
16% of India. The transaction is expected to be completed by H1FY2018. The management has
FII
26% guided that de-bottlenecking in the VSF division is likely to add 200 tonne/day of capacity
over phases and around 50 tonne/day of capacity would not require any capex. Moreover,
PRICE PERFORMANCE
the Caustic Soda capacity is on track to increase from 840KTPA to 1048KTPA in FY2018.
(%) 1m 3m 6m 12m
M
aintain Buy with unchanged price target of Rs1,150: We have increased our earnings
Absolute 12.0 -4.6 -4.1 35.4
estimates marginally for FY2017 and FY2018, primarily factoring in margin expansion in
Relative to Sensex 5.3 -3.4 -3.1 17.9
the VSF division. The improved outlook for UltraTech Cement is a positive for Grasim.
Consequently, we maintain our Buy rating with an unchanged price target of Rs1,150.
Sharekhan Limited, its analyst or dependant(s) of the analyst might be
holding or having a postition in the companies mentioned in the article. For detailed report, please visit the Research section of our website, sharekhan.com.
Hindustan Unilever
Buy CMP: Rs863 January 23, 2017
COMPANY DETAILS
Price target: Rs950
Demonetisation impacts Q3FY2017 performance;
Market cap: Rs186,846 cr gradual recovery anticipated; PT revised to Rs950
52-week high/low: Rs954/765
NSE volume (No of shares): 11.4 lakh KEY POINTS
BSE code: 500696 Volume declines by 4% YoY; revenue flat due to higher realisations; OPM down YoY: In
NSE code: HINDUNILVR Q3FY2017, HULs revenue stood flat at Rs8,317.9 crore, which was affected by a 4% YoY
Sharekhan code: HINDUNILVR decline in volume (due mainly to the demonetisation move). Despite lower volume, the
Free float (No of shares): 71.0 cr companys revenue came in flat due to higher realisation. Gross margins were down by
34BPS YoY at 47.6% and the OPM contracted by 76BPS to 16.3% due to higher raw material
SHAREHOLDING PATTERN
(RM) prices. The operating profit decreased by 5.2% YoY to Rs1,355.5 crore. Adjusting for the
Others exceptional item, the PAT declined by 10.4% YoY to Rs917.8 crore.
14% M
anagement outlook early signs of normalisation; steady growth momentum could be
FIIs seen from Q1FY2018: The HUL management has indicated that the early signs of recovery
13% from demonetisation were seen in most trade channels in December 2016. The consumers
purchase basket reduced substantially due to demonetisation, but most of them stuck to
Domestic their respective brands. The Southern and Western parts of India were the fastest to recover
Institutions Promoters from demonetisation vis--vis the Eastern and Central parts. Overall, the HUL management
6% 67%
expects a gradual improvement in sales in the coming months and foresees a steady revenue
growth from Q1FY2018 onwards. Though the RM prices are rising, the company will focus on
PRICE PERFORMANCE maintaining the OPM through prudent price hikes and several cost saving initiatives.
(%) 1m 3m 6m 12m
F
ine-tune estimates for FY2017/FY2018; maintain Buy with revised price target of
Absolute 7.4 3.3 -4.3 10.3 Rs950: We have fine-tuned our estimates for FY2017 and FY2018 to factor in lower-than-
Relative to Sensex 4.5 7.3 -1.6 -3.2 expected OPM and lower other income (we are introducing FY2019 estimates in this note).
We maintain our Buy recommendation with a revised price target of Rs950 (valuing HUL at
Sharekhan Limited, its analyst or dependant(s) of the analyst might be
35x FY2019E earnings).
holding or having a postition in the companies mentioned in the article.
For detailed report, please visit the Research section of our website, sharekhan.com.
IDBI Bank
Book out CMP: Rs82 February 07, 2017
COMPANY DETAILS
Price target: Rs16,830 cr
Weak operating performance,
Market cap: Rs86/47 marred by dismal asset quality
52-week high/low: 55.7 lakh
NSE volume (No of shares): 500116 KEY POINTS
BSE code: IDBI Not only has IDBI Bank posted weak set of numbers for Q3FY2017, but the asset quality
NSE code: IDBI has also deteriorated sharply. Gross Non-Performing Assets (GNPA) as a percentage of total
Sharekhan code: 53.57 cr assets increased by 211BPS QoQ to 15.16% while the Net Non-Performing Assets (NNPA) at
9.61% increased by 129BPS QoQ. Even on an absolute basis, the GNPA rose by 17% QoQ to
Free float (No of shares): 8.8 cr
Rs35,245.33 crore and jumped by 79.7% YoY. Exposure to the troubled economic sectors,
SHAREHOLDING PATTERN persistently high slippages and total stressed book of 26% (GNPA + Restructured) could keep
Public the banks performance subdued, while a lower capital adequacy ratio (Tier 1 of 8.5%;
26% CRAR of 11.3%) would be a key impediment to growth in advances. Moreover, the IDBI Bank
management does not expect any improvement in asset quality over the next 3-4 quarters.
The core business would also suffer due to weak corporate credit demand and the expected
pressure on Net Interest Margin (NIM).
Promoter
The IDBI Bank management has indicated that the NPA stress may remain elevated going
74% forward while growth in advances is expected to be muted in the near to medium term.
We expect that asset quality challenges for IDBI Bank will impact its other operating
PRICE PERFORMANCE parameters, which will be a negative. While mid-sized private sector banks have posted
strong Q3FY2017 results so far, we believe that larger Public Sector Banks (PSB) are also
(%) 1m 3m 6m 12m
likely to see improvement in their performance in the medium term. Therefore, private
Absolute 17.5 21.8 20.2 46.6
banks and PSBs present a better investment case vis--vis IDBI Bank. We are of the opinion
Relative to Sensex 10.5 16.8 18.3 25.0 that investors should exit IDBI Bank and shift to better managed private banks or larger
PSBs.
Sharekhan Limited, its analyst or dependant(s) of the analyst might be
holding or having a postition in the companies mentioned in the article. For detailed report, please visit the Research section of our website, sharekhan.com.
Infosys
Buy CMP: Rs975 January 13, 2017
COMPANY DETAILS
Price target: Rs1,150 Steady quarter despite challenges; maintain Buy
Market cap: Rs223,987 cr
52-week high/low: Rs1,278/900 KEY POINTS
NSE volume (No of shares): 37.3 lakh Beats estimates: Infosys CC revenue declined by 0.3% QoQ due to a weak volume growth
BSE code: 500209 of 0.2% QoQ, and a 1.1% QoQ drop in realisation. On a reported basis, the revenue in US
NSE code: INFY dollar terms declined by 1.4% QoQ to $2,551 million. EBIT margin expanded by 20BPS QoQ
Sharekhan code: INFY to 25.1%, led by better operational efficiencies, lower variable pay and the benefit of rupee
Free float (No of shares): 200.4 cr depreciation. As a result, the net profit grew by 2.8% QoQ to Rs3,708 crore. Infosys revised
SHAREHOLDING PATTERN its FY2017 revenue growth guidance to 8.4-8.8% on CC basis (from 8-9% earlier), reflecting
positive QoQ growth in Q4FY2017.
Public and
Others E
xpect recovery in FY2018, margins to remain in targeted range: (1) The Infosys
10%
management highlighted that a healthy deal pipeline and improvement in client spends will
Promoters accelerate the growth momentum in Q4FY2017 as well as in FY2018; (2) The management
Foreign 13%
58% kept unchanged its FY2017 EBIT margin band of 24-25%. It has sharpened its focus on fixed
price projects and role ratios to enhance the margins in the coming years; (3) Local hiring
Institutions
has been augmented materially amid the change in administration in the US. To address the
18% potential change in the US visa regime going forward, Infosys has been investing heavily on
automation, acquisition of local talent and delivery models.
PRICE PERFORMANCE
Valuation reasonable; visa overhang may restrict material outperformance: We have
(%) 1m 3m 6m 12m broadly maintained our earnings estimates for FY2017/FY2018 on account of a steady revenue
Absolute -2.0 -4.9 -16.7 -6.1 performance and positive management commentary. However, investors are concerned on
Relative to Sensex -3.5 -1.8 -15.6 -15.4 the magnitude of impact on the companys margins in case of any drastic change in the
US visa norms. Nevertheless, given the modest valuation and room for improvement, we
Sharekhan Limited, its analyst or dependant(s) of the analyst might be
maintain our Buy rating on Infosys with a price target of Rs1,150.
holding or having a postition in the companies mentioned in the article.
For detailed report, please visit the Research section of our website, sharekhan.com.
PRICE PERFORMANCE Valuation: The PV industry is poised for a better growth in FY2018 on the back of gradually
improving economic growth and easing of the tight liquidity situation. MSIL is well poised
(%) 1m 3m 6m 12m
to outpace the domestic PV industry growth, driven by a huge order backlog of recent
Absolute 10.4 0.4 30.9 40.7
launches and a strong product pipeline. We expect 11% volume CAGR and 14% topline CAGR
Relative to Sensex 5.0 3.3 32.4 23.8
over FY2017-FY2019. We retain Buy rating on the stock with an unchanged price target of
Rs6,430.
Sharekhan Limited, its analyst or dependant(s) of the analyst might be
holding or having a postition in the companies mentioned in the article. For detailed report, please visit the Research section of our website, sharekhan.com.
Persistent Systems
Buy CMP: Rs613 January 23, 2017
COMPANY DETAILS
Price target: Rs790
Investing in the right areas; Maintain Buy with an
Market cap: Rs4,901 cr unchanged price target of Rs790
52-week high/low: Rs796/501
NSE volume (No of shares): 0.9 lakh KEY POINTS
BSE code: 533179 Revenue beats estimate, but margins fall short of expectations: During Q3FY2017, PSL
NSE code: PERSISTENT
revenue grew by 4.6% QoQ to $110.0 million, driven by a 6.9% QoQ growth in IP-led revenue
and a 3.7% QoQ growth in IT Services. However, the company delivered lower-than-expected
Sharekhan code: PERSISTENT EBITDA margin at 15.9%, owing to reduced billing days. Forex gain increased by 327.3% QoQ,
Free float (No of shares): 5.1 cr led by depreciation in the rupee. This was partially offset by lower other income and higher
SHAREHOLDING PATTERN tax provision, resulting in an 11.4% QoQ growth in net profit at Rs81.9 crore.
E
xpect better growth in Q4FY2017: (1) The PSL management expects Q4FY2017 to be
Corporate
Foreign
23%
strong, as it has acquired new logos for its digital business. Further, the recent partnership
Bodies
2%
with Dell Boomi will drive its digital business going ahead; (2) The company has successfully
completed the transition of the IBM IOT business and could be able to take the entire
Institutions
Public and
Others
team into its Board. The management foresees traction in this IBM CE/CLM product and
14%
25% expects a strong growth in FY2018; (3) Digital, Alliance and Accelerite will continue to
deliver sustainable growth in the coming years; and (4) PSL is not perturbed about any
Promoters hostile regulatory developments in relation to the current US visa regime, as the company
36% has around 47% in terms of local US hires.
PRICE PERFORMANCE R
easonable valuation, long-term digital play; maintain Buy: We have marginally tweaked
our revenue estimates for FY2017/FY2018, led by higher-than-expected revenue growth
(%) 1m 3m 6m 12m in Q3FY2017, sharpening focus on IP and Digital businesses, and some green shoots in
Absolute 4.3 -7.8 -1.4 6.7 the Services business. We continue to remain positive on PSL, as the company has been
Relative to Sensex 1.5 -4.2 1.4 -6.4 continuously focusing on strengthening its digital capabilities to remain relevant to
customers in the ongoing IT industry transition. We maintain our Buy recommendation on
PSL with an unchanged price target of Rs790.
Sharekhan Limited, its analyst or dependant(s) of the analyst might be
holding or having a postition in the companies mentioned in the article. For detailed report, please visit the Research section of our website, sharekhan.com.
Raymond
Hold CMP: Rs505 January 27, 2017
COMPANY DETAILS
Price target: Rs550
Mixed performance;
Market cap: Rs3,100 cr Maintain Hold with revised price target of Rs550
52-week high/low: Rs654/351
NSE volume (No of shares): 22.7 lakh KEY POINTS
BSE code: 500330 Demonetisation affects performance in Q3FY2017: Raymond posted a muted performance
NSE code: RAYMOND in Q3FY2017, with revenue declining by 5.6% YoY to Rs1,306.9 crore, mainly due to lower
Sharekhan code: RAYMOND revenue across segments (barring Branded Apparels). In spite of gross margins staying
Free float (No of shares): 3.5 cr
stable, a spike in the Employee Cost and Other Expenditure led to a 49.7% YoY decline in the
operating profit to Rs58.5 crore. Due to the lower operating profit, Raymond reported a net
SHAREHOLDING PATTERN
loss of Rs14.7 crore as against a net profit of Rs39.1 crore in Q3FY2016.
C
ore Textile and Garments volumes decline substantially; Branded Apparel posts
Public & Others
34% Promoters moderate revenue growth: Raymonds Textiles business revenue fell by 11% YoY to
43%
Rs657.7 crore. Volume for this segment shrank in November-December due to weakness
in Wholesale and MBO channels, and curtailment in wedding expenditure due to the cash
crunch situation. The Branded Apparels business revenue grew by 6.5% YoY to Rs329.5
Domestic
Institutions Foreign
Institutions
crore due to a slowdown in demand in the traditional channels. The Garmenting segments
14%
9% revenue declined by 12% YoY to ~Rs129 crore and the Tools & Hardware segments volume
was affected by demonetisation in the domestic market and lower exports.
PRICE PERFORMANCE M
aintained Hold with revised price target of Rs550: We have reduced our FY2017/FY2018/
(%) 1m 3m 6m 12m FY2019 revenue and PAT estimates to factor in the dismal performance in Q3FY2017. We
Absolute 9.0 -18.0 12.9 30.6 expect the recovery to take some more time to materialise, considering the slowdown in the
Relative to Sensex 2.5 -16.9 14.0 13.7 overall discretionary consumer spending. Therefore, in view of the near-term headwinds,
we maintain our Hold recommendation on the stock with a revised price target of Rs550
and advise investors to avoid taking fresh positions in the stock at lower levels.
Sharekhan Limited, its analyst or dependant(s) of the analyst might be
holding or having a postition in the companies mentioned in the article. For detailed report, please visit the Research section of our website, sharekhan.com.
Reliance Industries
Buy CMP: Rs1,077 January 16, 2017
COMPANY DETAILS
Price target: Rs1,300
Strength in Petchem margin surprises positively;
Market cap: Rs349,379 cr Refining margin disappoints
52-week high/low: Rs1,129/889
NSE volume (No of shares): 32.6 lakh KEY POINTS
BSE code: 500325 Higher than expected Petchem margin and other income help beat earnings estimate:
NSE code: RELIANCE RIL reported Q3FY2017 PAT of Rs8,022 crore (+10% YoY), higher than our estimate of Rs7,742
crore on account of a better-than-expected Petchem EBIT margin of 15.5% and a higher
Sharekhan code: RELIANCE
other income of Rs3,025 crore (+32.6% YoY). GRM at $10.8/bbl was marginally lower than
Free float (No of shares): 178.1 cr
our estimate of $11/bbl, but the same was largely offset by a higher refining throughput
SHAREHOLDING PATTERN of 17.8mmt (vs our estimate of 17.5mmt). The Oil & Gas segment reported a loss of Rs125
Others
crore, as the domestic price declined by 18% QoQ to $2.8/mmbtu and the KG D-6 gas
22% production fell by 2.7% QoQ to 7.5mmscmd.
R
oGC project expected to come on stream shortly; Reliance Jio adds over 72mn
Promoters
DII 45% subscribers: The RoGC project is likely to come on stream in the near term and the major
12% utility systems of the Petcoke Gasification project have been charged to support the pre-
commissioning activities. Reliance Jio Infocomms (Reliance Jio) subscriber base stood at
FII 72.4 million as on December 31, 2016, and the company plans an additional investment of
21%
Rs30,000 crore in Reliance Jio to expand its network in terms of coverage and capacity.
PRICE PERFORMANCE M
aintain Buy and price target of Rs1,300: We have fine-tuned our earnings estimates for
FY2017 and maintain our FY2018E EPS at Rs114.9. We expect the refining margin to remain
(%) 1m 3m 6m 12m
firm, as oil demand growth is likely to be strong at around 1.3mbpd in 2017. Moreover, the
Absolute 4.9 3.1 8.1 2.3 likely commissioning of RILs Petcoke and RoGC projects would fuel earnings growth from
Relative to Sensex 2.8 4.5 9.9 -8.0 H2FY2018. Any positive news on Reliance Jio (in terms of subscriber retention post March
2017) could act as a positive trigger. We maintain our Buy rating and the price target of
Sharekhan Limited, its analyst or dependant(s) of the analyst might be Rs1,300.
holding or having a postition in the companies mentioned in the article. For detailed report, please visit the Research section of our website, sharekhan.com.
UltraTech Cement
Buy CMP: Rs3,518 January 23, 2017
COMPANY DETAILS
Price target: Rs3,950
Operational efficiency drives good performance
Market cap: Rs96,553 cr in a challenging climate; Upgrade to Buy
52-week high/low: Rs4,130/2,680
NSE volume (No of shares): 3.3 lakh KEY POINTS
BSE code: 532538 OPM sustained due to operational efficiency: UltraTech Cements Q3FY2017 revenue at
NSE code: ULTRACEMCO Rs5,540 crore (down 2% YoY; up 2.7% QoQ) was marginally affected by demonetisation.
Sharekhan code: ULTRACEMCO Lower volume of 11.4mt (down 0.6% YoY; up 2% QoQ) and reduced average blended cement
Free float (No of shares): 10.4 cr realisation of Rs4,860/tonne (down 1.4% YoY; up 0.7% QoQ) affected standalone revenue.
SHAREHOLDING PATTERN The Operating Profit Margin (OPM) at 18.9% was higher, as the company was able to contain
costs with a reduction in logistics expenditure and Fuel & Power cost. Further, lower
Public & others
11%
depreciation charge and reduced effective tax rate led to the adjusted standalone net profit
growing by 6.7% YoY to Rs563 crore.
Foreign G
reenfield 3.5mtpa capacity in Madhya Pradesh and JPs assets to increase cement
21%
capacity to 95mtpa: UltraTech will set up a 3.5mtpa cement plant in Madhya Pradesh (MP)
Promoter at a capital cost of Rs2,600 crore ($110/tonne). The plant is expected to start commercial
62%
MF & FI
6%
production from Q4FY2019, which is likely to lower the overall lead distance, apart from
meeting the demand in South West MP. Moreover, consolidation of JP groups cement assets
from Q1FY2018 would help the company in expanding its footprint in the Eastern region.
PRICE PERFORMANCE
U
pgrade to Buy with revised price target of Rs3,950: We have increased our FY2017E
(%) 1m 3m 6m 12m
and FY2018E EPS, factoring in better OPM. We expect a strong earnings growth going
Absolute 10.4 -13.4 -2.5 33.0
forward, backed by industry-leading volume expansion and superior operational efficiency.
Relative to Sensex 7.4 -10.0 0.3 16.6
Consequently, we assign a higher valuation multiple (due to improved earnings visibility)
and upgrade UltraTech to Buy with a revised price target of Rs3,950.
Sharekhan Limited, its analyst or dependant(s) of the analyst might be
holding or having a postition in the companies mentioned in the article. For detailed report, please visit the Research section of our website, sharekhan.com.
Wipro
Hold CMP: Rs473 January 25, 2017
COMPANY DETAILS
Price target: Rs550
Growth under a cloud;
Market cap: Rs115,090 cr maintain Hold with price target of Rs550
52-week high/low: Rs606/410
NSE volume (No of shares): 14.6 lakh KEY POINTS
BSE code: 507685 Revenue misses estimates, margin surprises positively: Wipros IT Services revenue for
Q3FY2017 stood at $1,902.8 million on Constant Currency (CC) basis, up 0.6% QoQ (below
NSE code: WIPRO
estimates). On a reported basis, Wipros total revenue was down by 0.7% QoQ to $1902.8
Sharekhan code: WIPRO million. IT Services EBIT margin improved by 50BPS QoQ (better than expectations), partly
Free float (No of shares): 65.0 cr due to one-off revenue from Designit and improved operational efficiency. Net profit grew
SHAREHOLDING PATTERN by 2% QoQ to Rs2,109.4 crore.
Multiple headwinds for growth in FY2018: The Wipro management stated that multiple
Institutions headwinds in the traditional business will continue for the remainder of FY2017, owing to:
6%
Corporate
(1) Expectations of challenges in the Healthcare sector spends in the US, owing to change
Bodies in the American leadership, while the HPS unit will be under pressure too; (2) Restructuring
2% of India and Middle East businesses will impact revenue for a few quarters; and (3) The
Promoters Foreign Communications vertical (7.4% of total revenue) will continue to see some softness going
13%
73% forward.
Public and
Others Acquires Brazils IT firm InfoSERVER SA for $8.7 million and divests EcoEnergy division
6% for $70 million: Continuing its acquisition spree, Wipro acquired InfoSERVER SA, an IT
service provider focused on Brazil for $8.7 million. InfoSERVER counts some of the largest
PRICE PERFORMANCE Brazilian banks as its clients. During the quarter, the company also divested its stake in the
(%) 1m 3m 6m 12m EcoEnergy division on a slump sale basis for a sale consideration of $70 million to United
Technologies Corporation (UTC).
Absolute 5.0 -0.5 -10.5 -11.5
Maintain Hold with price target of Rs550: Wipros traditional business continues to see
Relative to Sensex -0.2 2.3 -9.4 -22.2 multiple headwinds, which are unlikely to subside in the near term. We continue to remain
cautious on Wipros growth trajectory and maintain our Hold rating with an unchanged
Sharekhan Limited, its analyst or dependant(s) of the analyst might be
price target of Rs550.
holding or having a postition in the companies mentioned in the article. For detailed report, please visit the Research section of our website, sharekhan.com.
Zydus Wellness
Buy CMP: Rs865 January 31, 2017
COMPANY DETAILS
Price target: Rs960
Growth prospects to improve in coming quarters;
Market cap: Rs3,379 cr retain Buy with revised price target of Rs960
52-week high/low: Rs930/632
NSE volume (No of shares): 15,666 KEY POINTS
BSE code: 531335 Revenue flat but higher RM costs lead to lower PAT: During Q3FY2017, Zydus Wellness
NSE code: ZYDUSWELL revenue came in flat YoY at Rs102.6 crore, as the performance of its key brands (Sugarfree,
Sharekhan code: ZYDUSWELL Nutralite and Everyuth) was subdued due to the governments demonetisation move.
Free float (No of shares): 1.07 cr Consolidated gross profit margin contracted by 295BPS to 65.9%, owing to higher palm oil
SHAREHOLDING PATTERN prices. Due to a high operating cost, the operating profit dropped by 7% YoY to Rs22.25
crore. The reported PAT fell by 8.2% YoY to Rs25.1 crore.
Others
11% O
utlook - recovery likely to be faster due to wide presence in urban markets
FIIs predominantly through retail channels: Zydus Wellness also suffered in Q3FY2017 due to
8%
demonetisation. But, the companys performance was quite resilient, with sales coming in
Domestic
flat and sustained leadership position in the key categories. The management feels that
institutions Q4FY2017 would be better than Q3FY2017 because of the new launches/re-launches, and
9%
Promoters a better product mix and expects fast recovery to pre-demonetisation level due to a wide
72%
presence in modern trade (especially in urban markets).
PRICE PERFORMANCE M
aintain Buy with revised price target of Rs960: We have reduced our earnings estimates
for FY2017/FY2018 by 9%/2% to factor in the lower sales growth due to demonetisation. We
(%) 1m 3m 6m 12m
have introduced FY2019 estimates in this note. The company is confident of good revenue
Absolute 2.9 -0.7 10.4 16.0
growth in the coming quarters on account of a revamped distribution system and regular
Relative to Sensex -3.3 0.6 11.6 1.0
media & promotional initiatives to improve brand awareness. We have maintained our Buy
recommendation with a revised price target of Rs960.
Sharekhan Limited, its analyst or dependant(s) of the analyst might be
holding or having a postition in the companies mentioned in the article. For detailed report, please visit the Research section of our website, sharekhan.com.
Another quarter of tepid growth: With demonetisations nationwide liquidity situation should completely turn
adverse impact visible in earnings of Auto, Consumer and around by Q1FY2018 (April-June quarter). In such a
other domestic demand driven sectors, the aggregate scenario, the earnings growth would rebound to high
earnings of the Sensex companies for Q3FY2017 are double-digit levels in FY2018, largely due to a low base
expected to be lackluster - dashing hopes for a strong and normalisation of earnings in heavyweight sectors
revival in corporate earnings from H2FY2017. We like Banks, Energy and Consumer.
expect the aggregate earnings growth to be at 4.1% in
Valuation: Even though the earnings downgrades are
Q3FY2017. Even after adjusting for the usually volatile
expected to continue post Q3FY2017 results, the Price-
earnings of Banks and Energy companies, the growth
to-Earnings multiple of Sensex is at a reasonable level
rate would come to around 8.2% - which is unlikely to
and factors in the impending weakness in earnings for
improve market sentiments materially.
another couple of quarters due to demonetisation.
Revenue growth also muted; margins remain strong: Therefore, we continue to suggest buying a few carefully
The growth trend in revenue is also expected to be picked quality businesses in a systematic and phased
unexciting, but the margins will remain firm, with growth manner over the next few weeks, as was suggested in
at the operating level expected to be ahead of growth our earlier special report (Demonetisation: Shortterm
in revenue and earnings. However, the bad news is that pain, longterm gain) at the height of pessimism in
the flaring prices of crude oil and other commodities November (we had suggested 12 stock picks).
would put pressure on margins in the coming quarters.
The weakening of consumer demand in the wake of
Sensex one-year forward P/E band
demonetisation would also limit the pricing power of
Indian companies, which would find it difficult to pass 25.0
19.0
Jan-11
Jan-13
Jan-15
Jan-17
normalise by the end of February. Consequently, the Source: Bloomberg, Sharekhan Research
For detailed report, please visit the Research section of our website, sharekhan.com.
Sharekhan Limited, its analyst or dependant(s) of the analyst might be holding or having a
postition in the companies mentioned in the article.
The Nifty continues to form high tops, higher bottoms on the daily
KST (3.13835)
3 3
2 2
1 1
0 0
-1 -1
9000 9000
8900 8900
8800 8800
8750 8750
Given that it has reached the upper end of the channel, some
8700 8700
8650 8650
8550 8550
8450 8450
8400 8400
8300 8300
8200 8200
8150 8150
8050
8100
8050
7950
8000
7950
Support levels for the Nifty will be at 8673 and 8530 while the
7900 7900
7850 7850
7750 7750
10 17 24 1 7 15 21 28 5 12 19 26 2 9 16 23 30 6 13 20
Novem ber Decem ber 2017 February
The Index has witnessed a sharp rise after making a low of 7893.
KST (2.11900)
Interestingly, the Index has given a weekly close around the 78.6% 5 5
-5 -5
sessions. 9350
9300
9250
9200
9350
9300
9250
9200
9150 9150
of the previous move. Also, the upper end of the weekly Bollinger
8600 8600
8550 61.8% 8550
8500 8500
8450 50.0% 8450
8400 8400
Also, the Nifty is in wave (iv), which further confirms the possibility
100 100
0 0
-100 -100
-200 -200
-300 -300
9500
10000
9500
8000 8000
7000
7500
7000
bull market. The Index will head towards the upper end of the 6500 6500
5500
6000
5500
4500
5000
4500
3500 3500
A crucial support will be around 8327 and resistance will be around 3000 3000
8900. 2500
2000
2500
2000
1000 1000
Down 8530 8530 8900 8900 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
84.01%
82.42%
82.24%
81.99%
81.73%
81.45%
View
73.12%
69.97%
69.49%
40.00%
65.60%
63.10%
30.00%
20.00% On the options front, in the February F&O series 8500 PE
stands with the highest number of shares in OI followed
10.00%
0.00%
by the 8600 strike price. On the call side, the 9000 CE
Dec
Nov
Jan
Sep
Oct
Feb
72.8 85
68.3 59.7
84.5
68.2 72.3
59.2 84
02-Jan-17
04-Jan-17
06-Jan-17
08-Jan-17
10-Jan-17
12-Jan-17
14-Jan-17
16-Jan-17
18-Jan-17
20-Jan-17
22-Jan-17
24-Jan-17
26-Jan-17
28-Jan-17
30-Jan-17
67.8 57.7
02-Jan-17
04-Jan-17
06-Jan-17
08-Jan-17
10-Jan-17
12-Jan-17
14-Jan-17
16-Jan-17
18-Jan-17
20-Jan-17
22-Jan-17
24-Jan-17
26-Jan-17
28-Jan-17
30-Jan-17
EURINR GBPINR
USDINR JPYINR
67.9
38.2% 74.0
67.8
67.7 73.5
67.6
50.0%
67.5 73.0
67.4
72.5
67.3
61.8%
67.2
72.0
67.1
67.0 71.5
66.9
66.8 71.0
78.6%
66.7
70.5
66.6
66.5 70.0
66.4
66.3 69.5
100.0% 66.2
66.1 69.0
66.0
68.5
65.9
65.8
68.0
Aug Sep Oct Nov Dec 2016 Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2017 Feb Mar
Decem ber 2016 February March April May June July Augus t Septem ber Novem ber Decem ber 2017 February March
23.6% 95 64.0
94
63.5
93
92 63.0
91 62.5
90
62.0
89
38.2% 88 61.5
87 61.0
86
60.5
85
60.0
84
50.0% 83 59.5
82 59.0
81
58.5
80
58.0
79
78 57.5
61.8%
77 57.0
76
56.5
75
56.0
74
WEALTHOPTIMIZER PMS
The Indian equity market presents an excellent opportunity for the long-term investors. Sharekhan offers you solutions to meet your
financial objectives. WealthOptimizer is a portfolio management product that involves enhancing wealth over the long term. The goal is
to not only outperform the market but also generate superior returns.
Strategy
To invest in the most undervalued stocks of growing companies on the basis of reported financial performance
Disclaimer: Product is offered by Sharekhan Ltd (Registered Portfolio Manager with SEBI Regn. Nos. INP000000662 CIN No. U99999MH1995PLC087498) and having registered office at 10th Floor, Beta Building, Lodha
iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), Mumbai -400042, Maharashtra. Tel: 022-61150000. Email: igc@sharekhan.com, pms@sharekhan.com. This information does
not purport to be an invitation or an offer for services, client is required to take independent advise before opting for any service. Securities investments are subject to market and other risks and client should
refer to the risk disclosure document carefully. Past performance is no indication of future results. Future performance may vary. Detailed disclaimers and risk disclosure document is available on our website www.
sharekhan.com, please acquaint yourself with these before investing.
Endeavours to create a core portfolio of blue-chip companies with a proven Disclaimer: Returns are based on a clients
track record and have partial exposure to quality companies in the mid-cap returns since inception and may be different
space from those depicted in the risk disclosure
document.
PRICING
Top 10 stocks
Minimum investment of Rs25 lakh Britannia Industries
Charges
Hdfc Bank
2% per annum; AMC fee charged every quarter Il & Fs Transportation Networks
0.5% brokerage Indusind Bank
20% profit sharing after the 12% hurdle is crossed at the end of every fiscal
L&T Finance Holdings
Lupin
Rbl Bank
Reliance Industries
ZEE
FUND OBJECTIVE
A good return on money through long-term investing in quality companies
OVERVIEW
The ProTechIndex Futures Fund PMS strategy is suitable for long-term investors
who desire to profit from both bullish and bearish market conditions. The strategy Product performance
involves going long (buying) or going short (selling without holding) on Nifty futures as on January 31, 2017
by predicting the market direction based on a back-tested automated model. (In %) Scheme Sensex Nifty
*01-Feb-2006
A trending market or a volatile market with big moves is usually good for trend following
systems like ours. So, the first half of 2016 saw a drawdown due to range-bound moves in the
Nifty. However, we are witnessing a recovery now and expect the same to continue.
FUND OBJECTIVE
Absolute returns irrespective of market conditions.
OVERVIEW
Our ProTechTrailing Stops PMS strategy is ideal for Traders and Investors looking
for Regular Income from trading and desire to make profits in both bullish and
bearish market conditions. It is designed to payout book profits on monthly basis.*
Product performance
It is also for those investors who are looking for better income than Fixed Income
or Deposits. This strategy involves going Long (buying) or Short (selling without as on January 31, 2017
holding) on stock futures. (In %) Scheme Sensex Nifty
* Terms and conditions apply
1 Month 7.69 3.87 4.59
A risk model has been developed for stock portfolio allocation that reduces the FY 13-14 -1.06 18.85 17.98
risk and portfolio volatility through staggered building of positions.
FY 12-13 14.89 8.23 7.31
It is non-leveragedthe exposure will never exceed the value of the portfolio. FY 11-12 29.00 -6.10 -4.60
FY 10-11
PRICING FY 09-10
Minimum investment of Rs25 lakh
Since Inception* 42.45 49.26 54.23
Charges
Best Month 9.10 11.25 12.43
AMC fees: 0% Worst Month -5.09 -8.93 -9.28
Profit sharing: Flat 20% charged on a quarterly basis Worst Quarter -8.20 -12.69 -12.47
particular direction. We are now actively using position sizing as a means of building winning
positions in the direction of the trend. Position sizing is a method to minimise losses and is now
our core strategy followed by trailing stop losses to deliver regular income.
FUND OBJECTIVE
Absolute returns irrespective of market conditions.
For investors
PORTFOLIO DOCTOR
It is a service under which the Portfolio Doctor reviews an existing portfolio based on various parameters and suggests changes
to improve its performance. To avail of this service please write to the Portfolio Doctor at portfoliodoctor@sharekhan.com.
These ideas are put out in Sharekhans Pre-market Action report along 5% trailing Stop loss on 5% rise
Trail Stop loss
with stop loss and targets valid for a day. There is a market watch list in stock price
of stocks with positive and negative bias for intra-day traders. For A) Pre defined / Trail stop loss
Exit Rules
more details please write to us at premarket@sharekhan.com. is hit
B) Unexpected event/news/
MID DERIVATIVE CALLS outcome
These calls are based on the analysis of open interest, implied volatility
C) Time frame
and put-call ratio in the derivative market. It is a leveraged product
and ideal for aggressive traders. These calls have pre-defined stop Performance
Daily
loss, targets, time frame and quantity to execute. For details of the Reporting
product please write to us at derivative@sharekhan.com.
Report Card
MID performance* MID Derivative Calls performance*
Product New Alpha Delivery Picks Ticket size (Rs) 100,000
Month January 2017 FY2017
Month January 2017 FY2017
No. of calls 17 77
No. of calls 11 124
Open 3 3
Profit booked 18 55 Profit booked 8 65
Stop loss hit 0 19 Stop loss hit 3 59
Strike rate (%) 100 74 Strike rate (%) 73 52
Every individual has a different investment requirement, which depends on his financial goals and risk-taking capacities. We at Sharekhan first understand
the individuals investment objectives and risk-taking capacity, and then recommend a suitable portfolio. So, we suggest that you get in touch with our
Mutual Fund Advisor before investing in the best funds.n
Sharekhan Limited, its analyst or dependant(s) of the analyst might be holding or having a postition in the mutual funds mentioned in the article.
Every individual has a different investment requirement, which depends on his financial goals and risk-taking capacities. We
at Sharekhan first understand the individuals investment objectives and risk-taking capacity, and then recommend a suitable
portfolio. So, we suggest that you get in touch with our Mutual Fund Advisor before investing in the best funds.n
Sharekhan Limited, its analyst or dependant(s) of the analyst might be holding or having a postition in the mutual funds mentioned in the article.
Company CMP Sales Net profit (%) EPS PE (x) EPS RoCE (%) RoNW (%) DPS Div
(Rs) growth Rs. Yld(%)
FY16 FY17E FY18E FY16 FY17E FY18E FY16 FY17E FY18E FY18/FY16 FY16 FY17E FY18E FY17E FY18E FY17E FY18E
Thermax 830.5 4,352.0 4,056.0 4,239.0 305.0 284.0 313.7 25.6 23.9 26.3 1% 32.4 34.7 31.6 15.7 16.4 11.0 11.3 6.0 0.7
Triveni Turbine 125.8 796.3 913.0 1,053.0 107.6 142.0 162.0 3.3 4.3 4.9 23% 38.6 29.2 25.7 61.7 55.0 41.8 37.0 1.1 0.9
Va Tech Wabag 489.6 2,549.0 3,020.0 3,577.0 88.9 138.7 173.4 16.4 25.5 31.9 39% 29.9 19.2 15.3 17.8 19.8 13.3 14.9 4.0 0.8
V-Guard Industries 208.4 1,862.0 2,089.6 2,453.1 111.7 145.4 181.7 3.7 4.8 6.0 27% 56.2 43.3 34.7 37.3 37.1 27.5 27.7 3.5 1.7
Infra / Real Estate
Gayatri Projects 689.5 1,812.2 2,061.6 2,529.2 58.6 75.9 116.7 16.5 21.4 32.9 41% 41.7 32.2 21.0 10.3 11.9 9.0 12.5 2.0 0.3
ITNL 109.9 8,263.8 8,456.4 9,547.0 311.5 205.3 246.7 9.5 6.2 7.5 -11% 11.6 17.6 14.6 8.4 8.7 3.0 3.6 2.0 1.8
IRB Infra 234.0 5,130.2 5,882.7 6,795.8 635.8 679.7 754.4 18.1 19.3 21.5 9% 12.9 12.1 10.9 12.7 15.0 13.4 13.4 4.0 1.7
Jaiprakash Asso 13.0 8,793.8 - - (3,511.7) - - -14.4 - - - - - - - - - - 0.0 0.0
Larsen & Toubro 1,480.7 1,01,964.0 1,13,804.0 1,25,961.0 4,199.0 5,301.0 6,203.0 45.1 56.9 66.6 22% 32.8 26.0 22.2 7.9 8.9 11.6 12.6 14.3 1.0
NBCC 275.7 5,838.3 7,147.0 10,446.9 311.1 363.1 526.9 5.2 6.1 8.8 30% 53.2 45.6 31.4 37.4 45.7 22.5 27.8 2.0 0.7
Oil & gas
Oil India 344.8 9,765.0 9,795.0 10,515.0 2,545.0 1,986.0 2,243.0 31.8 24.8 28.0 -6% 10.8 13.9 12.3 9.8 10.7 8.7 9.5 12.0 3.5
Reliance 1,033.7 2,76,544.0 2,99,408.5 3,40,501.8 27,630.0 31,066.0 33,887.0 93.7 105.4 114.9 11% 11.0 9.8 9.0 9.1 9.2 11.5 11.3 10.5 1.0
Selan Exp 187.4 62.0 78.1 96.2 12.9 20.9 24.5 7.9 12.7 14.9 37% 23.7 14.8 12.6 9.2 10.4 7.2 8.1 5.0 2.7
Pharmaceuticals
Aurobindo Pharma 684.7 13,896.1 16,477.8 19,707.6 2,048.0 2,630.0 3,455.0 35.0 44.9 59.0 30% 19.6 15.2 11.6 29.4 33.1 31.6 30.6 2.5 0.4
Cipla 607.9 13,678.3 16,023.9 17,871.1 1,505.9 1,709.2 2,205.0 19.5 21.3 27.4 19% 31.2 28.6 22.1 12.7 14.8 13.2 14.7 2.0 0.3
Cadila Healthcare 365.1 9,837.6 9,556.8 10,941.9 1,522.6 1,213.4 1,567.2 14.9 11.9 15.3 1% 24.5 30.8 23.8 17.0 19.5 19.5 21.3 3.2 0.9
Divi's Labs 760.4 3,769.0 4,256.1 5,178.5 1,111.9 1,228.4 1,448.7 41.9 46.3 57.2 17% 18.1 16.4 13.3 32.3 32.9 26.3 26.7 10.0 1.3
Glenmark Pharma 947.3 7,650.0 9,499.0 10,272.0 1,068.0 1,451.0 1,631.0 37.8 51.4 57.8 24% 25.1 18.4 16.4 24.3 25.7 25.7 22.7 2.0 0.2
Lupin 1,492.0 14,208.5 17,022.9 20,420.4 2,270.7 3,035.1 3,791.7 50.4 67.4 84.1 29% 29.6 22.1 17.7 22.2 25.6 21.7 21.5 7.5 0.5
Sun Pharma 647.3 28,269.7 35,638.9 36,757.9 5,401.1 7,317.6 8,122.9 22.4 30.4 33.8 23% 28.9 21.3 19.1 23.5 24.2 19.2 17.9 3.0 0.5
Torrent Pharma 1,314.3 6,529.0 6,762.3 7,276.9 1,862.0 1,076.9 1,232.1 110.0 63.6 72.8 -19% 11.9 20.6 18.0 23.9 23.9 24.7 21.0 35.0 2.7
Building Materials
Grasim 944.3 34,654.3 36,017.1 40,790.4 2,434.5 3,280.5 3,837.2 52.2 70.3 82.2 26% 18.1 13.4 11.5 14.6 16.0 11.0 11.2 4.5 0.5
Shree Cement** 16,047.4 5,568.0 8,309.9 9,853.8 461.1 1,332.8 1,757.6 132.3 382.5 504.5 95% 121.3 41.9 31.8 21.4 22.7 19.6 21.3 24.0 0.1
The Ramco Cements 702.9 3,672.9 4,020.7 4,456.1 534.4 633.1 755.7 22.4 26.6 31.7 19% 31.3 26.4 22.1 11.5 12.4 18.7 18.8 3.0 0.4
UltraTech Cement 3,737.5 23,841.0 23,526.8 26,611.8 2,313.9 2,573.9 3,046.4 84.4 93.9 111.2 15% 44.3 39.8 33.6 14.7 16.1 11.2 11.8 9.5 0.3
Discretionary
Cox and Kings 194.7 2,351.9 2,206.8 2,514.2 284.9 279.5 382.5 16.8 16.5 22.6 16% 11.6 11.8 8.6 11.9 14.1 16.5 18.9 1.0 0.5
Century Ply (I) 215.7 1,664.0 1,813.0 2,273.9 160.5 175.7 212.9 7.2 7.9 9.6 15% 29.9 27.3 22.5 20.6 21.5 29.1 27.5 1.0 0.5
Inox Leisure 225.5 1,332.7 1,234.6 1,474.3 77.5 41.9 84.0 8.4 4.6 9.2 5% 26.8 49.0 24.5 10.0 15.0 6.6 11.7 0.0 0.0
Info Edge (India) 835.0 723.5 794.2 949.0 153.0 181.3 248.2 12.7 15.0 20.5 27% 65.7 55.7 40.7 14.0 16.6 9.4 11.6 3.0 0.4
KKCL 1,765.0 457.4 494.8 565.8 68.0 76.8 87.9 55.1 62.3 71.3 14% 32.0 28.3 24.8 27.9 28.0 24.1 24.2 60.0 3.4
Orbit Exports 327.4 150.0 116.0 139.0 23.0 19.2 24.2 16.0 13.3 16.8 2% 20.5 24.6 19.5 12.5 14.9 16.0 17.7 3.8 1.1
Raymond 503.8 5,621.0 5,286.0 5,590.0 92.0 69.5 93.6 15.0 11.3 15.2 1% 33.6 44.6 33.1 8.6 8.2 5.5 5.2 3.0 0.6
Relaxo Footwear 438.6 1,715.4 1,891.6 2,195.6 117.3 137.2 177.6 9.8 11.4 14.8 23% 44.8 38.5 29.6 28.6 35.2 19.0 21.9 0.6 0.1
Thomas Cook India 193.5 4,236.7 5,404.3 6,459.3 50.2 128.7 266.0 0.8 2.6 5.5 162% 241.8 74.4 35.2 10.5 19.5 13.4 22.0 0.4 0.2
Wonderla Holidays 376.8 205.4 267.9 336.8 59.8 32.8 57.1 10.6 5.8 10.1 -2% 35.6 65.0 37.3 12.1 20.3 8.1 13.8 2.0 0.5
ZEEL 495.9 5,851.5 6,439.1 7,210.4 933.1 1,277.8 1,637.3 10.2 13.3 17.1 29% 48.6 37.3 29.0 26.9 29.2 25.4 26.8 2.3 0.5
Diversified / Miscellaneous
Aditya Birla Nuvo 1,403.0 5,422.6 5,372.4 5,783.1 303.6 304.7 472.1 23.3 23.4 36.3 25% 60.2 59.9 38.6 7.0 7.3 3.7 5.4 5.0 0.4
Bajaj Holdings 2,026.6 469.8 - - 2,265.2 - - 203.5 - - - 10.0 - - - - - - 25.0 1.2
Bharti Airtel 353.8 96,619.2 97,549.5 1,04,090.8 4,735.3 4,511.5 3,591.5 11.8 11.3 9.0 -13% 30.0 31.3 39.3 10.7 8.6 6.2 5.6 1.4 0.4
Bharat Electronics 1,544.4 7,295.2 8,452.5 9,778.8 1,364.9 1,575.7 1,703.6 56.9 70.5 76.3 16% 27.1 21.9 20.2 17.8 17.0 13.2 12.6 17.0 1.1
Gateway Distriparks 258.8 1,046.1 1,099.5 1,196.7 123.6 108.3 134.5 11.4 10.0 12.4 4% 22.8 26.0 20.9 13.0 15.0 11.4 14.3 7.0 2.7
Max Financial 599.2 11,711.9 - - 252.7 - - 9.5 - - - 63.3 - - - - - - 0.0 0.0
PI Industries 933.7 2,096.8 2,495.2 2,984.2 300.0 399.6 475.5 22.2 29.6 35.2 26% 42.1 31.5 26.5 34.6 34.1 30.0 27.6 3.1 0.3
Ratnamani Metals 669.3 1,719.0 1,497.3 1,800.9 162.7 139.8 172.2 34.8 29.9 36.8 3% 19.2 22.4 18.2 16.9 19.0 12.8 14.1 5.5 0.8
Supreme Industries** 964.7 2,974.8 4,240.3 5,504.7 212.0 361.2 477.1 16.7 28.4 37.6 50% 57.8 33.9 25.7 26.7 31.7 22.9 24.9 7.5 0.8
UPL 738.2 13,301.5 16,005.0 18,786.0 1,438.9 1,815.3 2,285.7 27.6 35.8 45.1 28% 26.7 20.6 16.4 18.3 19.3 22.2 22.7 5.0 0.7
Remarks
Automobiles
Apollo Tyres Apollo Tyre is the market leader in truck and bus tyre segments with a 28% market share in India. The company has invested $600 million
in the past to set up a greenfield facility in Hungary and Rs4,000 crore to expand capacity at Chennai facility. The expanded capacities
are likely to come on stream by 2017-18. Also the recent foray in the 2 wheeler tyres strengthens Apollo Tyres presence across all the key
automobile segments. With the liquidity situation improving post the demonetisation move (announced in early-Nov 2016), ATLs domestic
market OEM sales are expected to improve going ahead. Further, with the Union Budget increasing the allocation for infrastructure
development, the tyre replacement segment is likely to gain pace going forward. Further, the European operations are seeing a double-
digit volume growth after the company sorted out capacity related issues in H1FY2017. The new plant in Hungary would commence
operations in Q1FY2018 and the company has already tied up with various OEMs to commence supplies. We expect ATLs topline to grow
at a 12% CAGR over FY2017-FY2019. Natural Rubber prices have surged by 50%/31% in the international/domestic markets in the last
3-4 months. Also, crude oil prices have increased by 8%. ATL has indicated that it expects a ~10% increase in the RM cost in Q4FY2017.
Although ATL has undertaken a 1.5% price hike, it is unlikely to pass on the full increase in RM costs, which will lead to lower margins. We
expect the OPM to drop to 13% in FY2018 from 15% in 9MFY2017. We retain our Hold rating on the stock with a revised price target of
Rs200.
Ashok Leyland Ashok Leyland, the second largest CV manufacturer in India, is a pure CV play. The demonetisation move adversely impacted the overall
Commercial Vehicle (CV) volume in November-December 2016, with the industry sales dropping by 13% YoY. ALLs volume declined by
4% YoY during the same period. At present, the situation has improved considerably, as the tight liquidity situation has eased, resulting
in better working capital management for the fleet operators. Further, the truck prices are set to rise by ~7-8% from the current level
due to the implementation of the new emission norms effective April 2017 and the likely rollout of the new cab code, which will make
air conditioning in the CVs mandatory. This is expected to result in a significant amount of pre-buying in Q4FY2017 and we expect CV
volume to grow by 16% YoY in Q4FY2017 and at high single-digit rate in FY2018. Given the pressure on volume due to demonetisation,
the MHCV industry resorted to heavy discounting (Rs300,000 per vehicle up from Rs250,000 per vehicle earlier) to push sales. The
discounting levels are expected to ease, as the volume growth gains traction and the cash crunch situation eases further at the fleet
operators end. This, along with the price hikes taken in January 2017 will expand the OPM to 11.9% in FY2018 from 10.3% in Q3FY2017.
We maintain our Buy recommendation with a revised price target of Rs105.
Bajaj Auto Bajaj Auto is a leading motorcycle and Three Wheeler (3W) manufacturer with a significant presence in the overseas markets. In the
domestic market, it is a leader in the premium motorcycle segment. The launch of CT100 and refreshed Platina in the recent past
has given a much needed volume push while the newly launched Pulsar variants, Avenger and V-series have helped consolidate its
leadership in the premium and luxury motorcycle segments. The launch of the Dominar 400 would help the company gain further market
share in the premium motorcycle segment. Improved cash availability (post demonetisation), better rural sentiments (due to enhanced
Rabi sowing) and higher Minimum Support Prices (MSPs) are likely to propel growth for the domestic motorcycle industry going forward.
With the recent new launches (Pulsar NS200 and Dominar), BAL is likely to continue winning market share in FY2018. We expect
BALs domestic volume to grow in double digits in FY2018. The macro-economic issues (sharp currency depreciation) in the key export
markets including Nigeria have affected the dispatches to these countries and the impact is likely to be felt for another couple of quarters.
Also Bajaj Auto is likely to face a steep competition in the key exports markets as competitors TVS and Hero are stepping up presence.
Domestic volume is likely to recover in FY2018 while we expect the export volume to remain under pressure in the near term. We retain
our Hold rating on the stock with a revised price target of Rs3,000.
Gabriel India Gabriel is one of Indias leading manufacturers of shock absorbers and front forks with a diversified customer base. Gabriels revenues
are expected to grow at a healthy 15% CAGR over FY2016-FY2018 due to improved outlook for the two-wheeler industry and the
passenger car segments. There has been a ramp-up in supplies to Honda Motorcycle & Scooters (HMSI) new plant in Gujarat, as also to
the new models of Maruti Suzuki and Mahindra & Mahindra (M&M). In the near term, the stock performance would be influenced by the
recovery in the two-wheeler market, a likely positive rub-off from the implementation of the Seventh Pay Commissions recommendations
and expectations of a normal monsoon in 2016. The recent demonetisation move will impact demand, especially in the 2W segment
(where transactions are cash based). GIL believes that demonetisation will impact demand in Q3FY2017 but the long-term growth outlook
is strong. Apart from the RM cost reduction, GIL is also working on controlling the overhead costs through productivity improvement. GIL
is targeting to reach double-digit OPM as against 9.4% OPM in H1FY2017. We maintain our Buy rating on the stock with an unchanged
PT of Rs130.
Hero MotoCorp HMCL is the largest two-wheeler manufacturer in the world with sales of over 6.6 mn vehicles in FY16 and a domestic market share of
39%. We expect the two-wheeler industry to grow at 10-12% CAGR over the next five years driven by increased penetration levels in rural
areas and replacement demand. HMCL is expected to maintain its leadership position in the industry with new launches in the premium
motorcyles and scooters segments. Further, massive capex plans implemented by the company in the past, shall ramp up the production
levels. The Governments decision to demonetise the high-value currency notes is likely to result in a cash crunch and defer discretionary
consumer purchases such as Two-Wheelers (2W). The impact is expected to be severe in the rural areas where a large chunk of
transactions are cash-based. This is likely to impact rural-focused automobile players, including Hero MotoCorp. However, the volumes
are likely to recover in the next 6-8 months once the macro-economic environment attains stability. Therefore, we believe that Heros
long-term growth prospects are intact but it will experience some pressure in the near term. We maintain our Buy recommendation with
a revised price target (PT) of Rs3,500.
M&M M&M is a leading maker of tractors and UVs in India. We expect demand for the automobile segment to pick up with an improvement
in customer sentiment. Additionally, new launches especially in the compact UV space will drive volume growth. After growing in strong
double digits, the tractor demand was under pressure in FY15-16 due to weak monsoon. Tractor sales improved significantly in H1FY2017
and the management expects the demand traction to sustain going ahead. M&M is working on launching a new platform for Tractors in
the sub-30 HP category in H1FY2018 and we expect Tractor demand to grow at 16% CAGR over the next two years. However, near-term
concerns like demonetisation are likely to impact demand in the short term (transactions in rural areas where M&M has strong presence
are predominantly done in cash). We expect M&Ms topline and bottomline are likely to grow at 13% and 16% CAGR, respectively
between FY2016 and FY2018. While the long-term demand potential is strong, the same is likely to be impacted in the near term. We
have reduced our earnings estimates by 3% and 8% for FY2017 and FY2018, respectively to factor in the impact on volume. We maintain
our Buy rating on the stock with a revised price target of Rs1,450.
Maruti Suzuki Maruti Suzuki is Indias largest passenger vehicle maker with a strong 46% market share. It has been able to gain market share over
the last two years on the back of a diverse product portfolio, a large distribution network with an increased focus on rural markets and a
shift in consumer preference to petrol models from diesel. The premium hatchback, Baleno and Compact SUV Vitara Brezza command a
waiting period of six months each while the newly launched Ignis has a waiting period of two months. This will help the company expand
market share in the segment. The management plans to double its existing sales and distribution network in order to achieve its target
of doubling domestic volumes over the next five years. Maruti is likely to outpace the PV industry growth rate in FY2017-FY2018 on the
back of sustained strong demand for recent launches and a robust product pipeline. The commissioning of the first phase of Gujarat plant
will further aid volume expansion. MSILs yen exposure is expected to reduce with a higher localisation level while the royalty on future
models shall be INR denominated, thus shielding the OPMs partly. Also, Operating Profit Margin (OPM) is expected to improve on the
back of operating leverage and lower discounts due to strong demand. The Governments demonetisation move is unlikely to have any
material impact on Marutis volumes given the higher proportion of financing in its sales, and a long waiting period on recently launched
models (Baleno and Vitara Brezza). Further, Marutis FY2018 volume growth would be higher, driven by the expected resurgence in
demand post demonetisation and the planned new launches. We maintain our Buy rating with a revised price target of Rs6,430.
Rico Auto Inds. Rico Auto is one of the largest producers of high-pressure non-ferrous die castings for the auto sector. The significant cash inflow due to
stake sale in a JV company has enabled it to deleverage its balance sheet. Additionally, a lower interest burden will result in a growth in
the earnings and free cash flow. Further, improved demand outlook from the key customers - Hero MotoCorp, Maruti Suzuki and Renault
(60-65% of total revenue), coupled with commissioning of the Chennai plant will boost the companys topline going forward. Also, the
proposed new plant at Rajasthan is expected to commence operations by Q3FY2018 and will start contributing to the topline. Driven by a
strong demand outlook and consequent plans to ramp up capacity, we expect Ricos revenue to grow at 14.5% CAGR between FY2016
and FY2018. Further, the companys margins are also likely to improve due to a better product mix, operating leverage and improved
profitability of subsidiaries/JV. We maintain our Buy rating and raise our price target (PT) to Rs84.
TVS Motor TVS Motor is the fourth largest two-wheeler manufacturer in the country with a strong presence in the scooter segment. The scooter
segment has surpassed the growth in the motorcycle segment over the past couple of years and currently contributes 30% of the total
two-wheeler volumes. On the motorcycle front, two new launches in January 2016 (Apache RTR and Victor) have generated higher
volumes for the company TVSM is poised to outpace the 2W industry growth given the new launches and sustained demand for its
products. TVS has a higher share of Mopeds and Scooters (their combined contribution in TVS 2W volumes is 60% as against industry-
wide average proportion of ~36%), which have been less affected by demonetisation being utilitarian products. The alliance with BMW
would further aid topline growth. We also believe that the alliance with BMW would be a game changer for TVSM, as it would enhance
its brand image in the premium motorcycle category. Also, the technological inputs received from BMW would significantly enhance the
brand appeal of the entire TVSM product range, enabling it to command higher margins. Benefits of operating leverage, better product
mix and alliance with BMW are expected to aid in margin expansion over the next 1-2 years. We expect TVS to outpace the 2W We retain
our Buy rating with a revised price target of Rs455.
Bank of Baroda Bank of Baroda is among the top public sector banks (PSBs) having a sizeable overseas presence (over 100 offices in 24 countries) and
a strong network of over 5,000 branches across the country. It has a stronghold in western and eastern India. Its performance metrics
remain better than that of the other PSBs and asset quality has deteriorated in line with the RBIs directive to clean the balance sheet.
Bank of India Bank of India has a network of over 4,800 branches, spread across the country and abroad, along with a diversified product and services
portfolio, and steadily growing assets. The operating performance and earnings have eroded significantly due to margin deterioration and
sharp rise in NPAs. Given the rise in the number of incremental stressed loans and the relatively weaker capital position, its valuations
may remain subdued.
Capital First Capital First (erstwhile Future Capital Holdings) had been acquired by global private equity firm, Warburg Pincus (a 72% stake). The
present management has taken several initiatives to tap the high-growth retail product segments, like gold loans, loan against property
and loan against shares. It has a strong CAR and sound asset quality. Its loan book is expected to sustain a 25-30% growth in the next
three years. As a result of several initiatives taken, the operating leverage will play out and may lead to significant pick-up in profitability
over medium term.
Corp Bank Corporation Bank is a mid-sized PSB having a relatively higher presence in south India. It is predominantly exposed to the corporate
segment, which constitutes about 45% of its book. Due to a higher dependence on the wholesale business and a low CASA ratio, it lags
its peers in terms of operational performance. Also, the rise in NPAs could keep provisioning high and weaken earnings performance.
Federal Bank Federal Bank is among the better performing old private sector banks in India with a strong presence in south India, especially Kerala.
Under the new management, the bank has taken several initiatives, which would improve the quality of its earnings and asset book.
The asset quality has shown stress in the past few quarters, though we expect a gradual improvement in the NPAs and the operating
performance to pick up gradually. The valuations seems attractive over the medium to long term.
HDFC HDFC is among the top mortgage lenders providing housing loans to individuals, corporates and developers. It has interests in banking,
asset management and insurance through its key subsidiaries. As these subsidiaries are growing faster than HDFC, the value contributed
by them would be significantly higher going forward. Due to a dominant market share and consistent return ratios, it should continue to
command a premium over the other NBFCs. Any unlocking of value from its insurance business will be positive for the stock.
HDFC Bank HDFC Bank is among the top performing banks in the country having deep roots in the retail segments. Despite the general slowdown in
the credit growth, the bank continues to report a strong growth in advances from retail products. Its relatively high margins (compared with
its peers), strong branch network and better asset quality make HDFC Bank a safe bet and there is scope for expansion in the valuations.
ICICI Bank ICICI Bank is Indias largest private sector bank with a network of over 3,800 branches in India and a presence in around 18 countries.
The bank has made inroads into retail loans (~45% of the book) and significantly improved its liability franchisee. The operating profit
improved significantly though its exposure to some troubled sectors (infrastructure, steel etc) has increased pressure on the asset quality.
However, a healthy growth in the operating income and proceeds from monetisation of the stake in subsidiaries will help to deal with the
NPA challenges.
LIC Housing LICHFL is the third largest mortgage financier (including banks) in India with a market share of 11% and loan book of over Rs1,00,000
crore. It is promoted by Life Insurance Corporation of India, which is among the most trusted brand in the country. With over 200 branches,
1,241 direct sales agents, 6,535 home loan agents and 782 customer relationship associates, the company has among the strongest
distribution structures in India to support business expansion. Going ahead, a revival in the economy and moderation in the borrowing
rates could be the key triggers for the stock. Therefore, considering stable RoE of ~20%, sound asset quality and healthy growth outlook,
the companys fundamentals are strong.
PNB Punjab National Bank has one of the best liability mixes in the banking space, with low-cost deposits constituting around 40% of its
total deposits. This helps it to maintain one of the highest margins among PSBs. However, in view of the weakness in the economy and
relatively higher exposure to troubled sectors, the asset quality stress has increased and NPA issues will persist over next few quarters.
PFS PTC India Financial Services, owned by PTC India, is focused on providing financial solutions to projects in the energy value chain. Given
the robust lending opportunities in the renewable energy segment and the likely reforms in the thermal power segment, the loan growth
is expected to remain strong over the next two to three years. The proceeds from exits in investments would add to the profitability. The
asset quality despite some deterioration is manageable.
SBI State Bank of India is the largest bank of India with loan assets of over Rs14 lakh crore. The successful merger of the associate banks and
value unlocking from insurance business could provide further upside for the bank. While the bank is favourably placed in terms of liability
base and the operating profit is also better than peers; the asset quality has emerged as a key pain point which will affect the earnings
growth.
Union Bank Union Bank of India has a strong branch network and an all-India presence. The bank aspires to become the largest retail, MSME bank.
Hence, it has ramped up its manpower and infrastructure to ramp up retail, SME lending. The banks asset quality challenges have come
to fore (mainly from the corporate portfolio) whereas low tier-1 CAR also remains an area of concern.
Yes Bank Yes Bank, a new generation private bank, started its operations in November 2004 and has emerged as among the top performing banks.
It follows a unique business model based on knowledge banking, which offers product depth and a sustainable competitive edge over
established banking players. The bank is suitably poised to ride the recovery in the economy and the retail deposit franchise is showing
a sharp improvement which will support the margins in the medium to long term
Consumer goods
Britannia Britannia is the second largest player in the Indian biscuit market with about 30% market share. Under a new leadership, Britannia has
been able to leverage and monetise its strong brand and position in the biscuit and snack segments. The company can sustain its higher
than industry growth rates with an improving distribution reach, entry into newer categories and focus on cost efficiency. There will be
some impact on the business in the near term due to demonetisation. However, the long-term growth strategy will remain intact. We
recommend a Buy on the stock with a price target of Rs3,950.
Emami Emami is one of the largest players in the domestic FMCG market with a strong presence in the under-penetrated categories such as
cooling oil, antiseptic cream, balm and mens fairness cream. The recently acquired Kesh King brand improves the product and margin
profiles of the company. The desire to become a large FMCG player by riding on a portfolio of differentiated brands and widening reach in
various geographies will help Emami to achieve a growth of over 20% CAGR over the next 2-3 years. The management expects volume
growth to recover to 10-12% in the near to medium term and to on enhance the direct distribution reach. We recommend a Buy on the
stock.
GSK Consumer GSK Consumer Healthcare is a leading player in the MFD segment with ~70% share in the domestic market. Judicious new launches and
brand extensions, and the expansion of its distribution reach have helped it to stay ahead of the competition and maintain its pricing power
over the years.. There will be some impact on the business in the near term due to demonetisation, but the long-term growth strategy will
remain intact. In a bid to de-risk its business model, it has expanded its product portfolio by entering into new categories such as biscuits
and oats in the recent years. With cash balance of more than Rs2,500 crore, the company can invest in growth initiatives and/or reward
its shareholders with a healthy dividend payout.
GCPL Godrej Consumer Products is a major player in personal wash, hair colour and household insecticide market segments in India. The recent
acquisitions, ie Strength of Nature, Darling Group, Tura, Megasari and Latin American companies, have helped the company to expand
its geographic footprint and improve growth prospects. GCPL is expected to be relatively less affected by demonetisation compared to
other FMCG companies, as its domestic business constitutes ~50% of overall consolidated revenue. The GCPL management expects
the domestic business to recover in Q4FY2017. Further, the companys international business is expected to post a better performance,
underpinned by the revival in Indonesia and expectations of strong revenue growth and improvement in profitability in Africa. We have
upgraded our rating from Hold to Buy with a revised price target of Rs1,750.
HUL Hindustan Unilever is Indias largest FMCG Company. The HUL management expects a gradual improvement in sales in the coming
months and foresees a steady revenue growth from Q1FY2018 onwards. Also, the supply chain and distribution systems are already
in the process of getting into the GST mould. Being present in the essential consumer goods categories, HUL will be one of the key
beneficiaries of GST implementation. we maintain our Buy recommendation with a revised price target of Rs950 In the long term, it will
be one of the key beneficiaries of the Indian consumerism story.
ITC ITC has a strategy of effectively utilising the excess cash generated from its cash cow, the cigarette business, to strengthen and enhance
its other non-cigarette businesses. This would nurture the growth of these businesses some of which are at a nascent stage. The quantum
of excise duty of 6%declared in the Union budget 2017-18 was much lower than in the earlier years. This should help in stabilizing
cigarette sales volume in the coming years. The current valuation makes ITC one of the cheapest stocks in the large-cap FMCG space.
Jyothy Labs Jyothy Laboratories is the market leader in the fabric whitener segment in India. With the successful integration of Henkel and the
induction of a new management team led by S Raghunanadan, it has transformed itself from a one-brand wonder to an aggressive FMCG
player. We expect JLL to see an early recovery (due to demonetisation) because of its strong presence in South India, which has high
penetration of non-cash transactions. Further, the company is focusing on enhancing its direct distribution reach.
Marico Marico is among Indias leading FMCG companies. Its core brands, Parachute and Saffola, have a strong footing in the market. It
follows a three-pronged strategy which hinges on expansion of its existing brands, launch of new product categories (especially in the
beauty and wellness space) and growth through acquisitions Marico is feeling the pinch from the Governments demonetisation measure,
with its sales expected to be lower in H2FY2017. Marico is one of the strongest players in the domestic branded Hair Oil and Edible Oil
markets, with a leadership position in both the categories. With less exposure to Rural India, we expect Marico to see a faster recovery
when the demonetisation pain abates, owing to strong brands and a wide distribution reach of 4.5 million outlets. Due to the recent stock
correction, we maintain our Buy recommendation with a revised price target of Rs290
Zydus Wellness Zydus Wellness has small product portfolio, consisting of just three brands (Nutralite, Sugar Free and Everyuth) that cater to a niche
category. The Zydus Wellness management is confident of good revenue growth in the coming quarters on account of a revamped
distribution system and regular media & promotional initiatives to improve brand awareness (largely in the urban markets). The company
is aiming to improve the growth prospects of its key categories by regular new product/variant additions and plans to expand its footprint
into the international markets.
IT/IT services
Firstsource Firstsource Solutions is a specialized BPO service provider. The management continues to maintain its FY2017 revenue growth guidance
(10-12% YoY on CC terms). However, the management believes that margins could be adversely impacted, owing to softness in the
mortgage business, mounting hiring cost for expansion of customer base in Healthcare and unfavorable currency movements. The
health of its balance sheet is improving gradually as the company is gradually reducing its debt burden through internal accruals. The
company expects to be comfortably net cash positive by the end of FY17. We expect the ongoing macro overhang to restrict the stocks
outperformance in the near-to-medium term, as FSL has 38.1% exposure to the UK.
HCL Tech HCL Technologies has a leadership position in ERD and IMS space, together accounting for ~58% of the companys total revenue. The
management believes that cross-selling to the existing ERD and IMS clients could unravel a larger business opportunity going forwardThe
company has not shied away from taking the inorganic route (10 acquisition/partnerships in the last 18 months) to strengthen its offerings.
In addition, the management has made investments in digital technologies (DRYiCE), which will catapult the company to the next level
of growth during the ongoing digital transition. We remain positive on the company in view of its large order wins, acquisitions in the ERD
space, investments in applications space and superior earnings visibility.
Infosys Infosys is Indias premier IT and IT-enabled Services Company that provides business consulting, technology, engineering and outsourcing
services. It has also given a promising aspiration target for 2020 of achieving $20bn in revenues and 30% in margin. Under the leadership
of Vishal Sikka, the company is doing the right thing by investing in the digital space (both organic and inorganic), improving client
engagement through design thinking, and automation. We remain positive on the companys growth prospects for the coming years.
Persistent Persistent Systems has proven expertise and a strong presence in newer technologies, strength to improve its IP base and the best-
in-the-class margin profile which set it apart from the other mid-cap IT companies. PSL is focusing on the development of IoT products
and platforms, as it sees significant traction from Industrial Machinery, SmartCity, Healthcare and Smart Agriculture verticals. Further, led
by the recent acquisitions and alliance with IBM to build IoT solutions for IBMs Watson platform, we expect the revenue momentum to
accelerate in FY2017/FY2018 and the margins are likely to remain stable on the back of the initiatives taken by the company.
TCS Tata Consultancy Services is among the pioneers of the IT services outsourcing business in India and is the largest IT service firm in the
country. Its management expects the digital revenues to grow much faster in the coming years; these grew by 52.2% YoY to $2.3 billion
in FY16. The management noted that headcount addition will be materially lower than in FY16 and dependence on Visas will come down.
We believe that the ongoing transition phase of the IT industry and the weak spending environment will restrict stock outperformance in
the medium term. On a longer term basis, we still prefer TCS, owing to its diversified portfolio and head-start in the Digital space.
Wipro Wipro is among the top five IT companies in India but in the last few years it has been lagging the industry in terms of growth. We believe,
owing to weakness in the energy, telecom, and some project deferrals, its unlikely to show material improvement in earnings on an
organic basis in FY17. The management has given an ambitious target of $15 billion revenues and 23% margin by 2020. We see the
target of new CEO Abid Ali Neemuchwala as an uphill task looking at the current growth trajectory. Therefore, we remain sceptical, as
anecdotal evidence on Wipro in the last two to three years does not inspire confidence.
Capital goods/Power
BHEL Bharat Heavy Electricals, Indias biggest power equipment manufacturer, has been the prime beneficiary of the multi-fold increase in the
investments made in the domestic power sector over the last few years. However, the order inflow has been showing signs of slowing
down which would remain a major concern for the company. The key challenge before the company now would be to maintain a robust
order inflow and margin amid rising competition and lower order inflow.
CESC CESC is the power distributor in Kolkata and Howrah (backed by 1,225MW of power generation capacity) which is a strong cash
generating business. Further, 600MW of regulated generation capacity (to serve Kolkata distribution) has come on stream recently in
Haldia. Also its 600MW thermal power project at Chandrapur has signed PPA and started operating. The losses in the retail business are
coming down gradually over the past and it is expected to break even soon. The BPO subsidiary, FirstSource, is performing well in line
with expectations. However, the recent diversification into unrelated businesses like IPL franchisee would hurt its valuations.
Crompton Greaves Crompton Greaves key businessesindustrial and power systemsare passing through a rough patch and are potential beneficiaries
of the upcoming investment cycle revival. Also, the company is looking to unlock value by selling its international subsidiaries.
Finolex Cables Finolex Cables, a leading manufacturer of power and communications cables, is set to benefit from an improving demand environment in
its core business of cables. It is leveraging its brand strength to build a high-margin consumer product business. It has recently launched
Fans and switch Gears. Further, it is planning to launch water Heaters soon. Addition of new products in the product portfolio could be the
next growth driver. We see a healthy earnings growth, return ratios in high teens and superior cash flows which bode well for the stock.
Hence, we remain positive on the stock.
Greaves Cotton Greaves Cotton is a mid-sized and well-diversified engineering company. Its core competencies are in diesel/petrol engines, power
gensets, agro engines, pump sets (engine segment) and construction equipment (infrastructure equipment segment). The management
has taken a strategic call to close and hive off the loss-making infrastructure equipment division. A positive outlook for all the business
segments, coupled with the companys ongoing efforts to launch new products and widen its geographical reach is likely to drive topline
going forward. Further, GCL is ready with Bharat Stage 4 compliant engines (Bharat Stage 4 to be implemented from April 1, 2017 pan-
India), which will further aid topline growth in FY2018. We expect GCLs topline to grow at 10% CAGR between FY2016 and FY2018. We
remain positive on the stock and maintain our Buy rating with a price target of Rs160.
Kalpataru Kalpataru Power Transmission is a leading EPC player in the transmission & distribution space in India. Opportunities in this space are
likely to grow significantly, thereby providing healthy growth visibility. The OPM of the stand-alone business is likely to remain around 10%;
however the OPM of JMC Projects (a subsidiary) is showing signs of improvement. We see some value unlocking potential from selling
assets or listing of new business in future. We remain positive.
PTC India PTC India is a leading power trading company in India with a market share of 35-40% in the short-term trading market. In the last few
years, the company has made substantial investments in areas like power generation projects and power project financing which will
start contributing to its earnings. We retain our positive stance on expected healthy volume uptick, with an increasing share of long-term
contract business.
Skipper Skipper is uniquely placed to exploit the growing opportunities in two lucrative segments: power (transmission tower manufacturing
and EPC projects) and water (PVC pipes). It has a comfortable order book of more than Rs2,400 crore in the transmission business,
which looks promising given the huge investments proposal by the government in the power T&D segment in the next five years. It has
expanded the PVC capacity manifold (4x) and aspires to turn a national player from a regional player.
Thermax The energy and environment businesses of Thermax are direct beneficiaries of the continuous rise in India Incs capex. Thermax group
order book stands at around consolidated revenues. However, the company has shown its ability to maintain a double-digit margin in a
tough environment. We retain Hold on the stock due to its rich valuation.
Triveni Turbines Triveni Turbines (TTL) is a market leader in 0-30MW steam turbine segment. TTL is at an inflexion point with a strong ramp-up in the after-
market segment and overseas business while the domestic market is showing distinct signs of a pick-up. The company has also formed
a JV with GE for steam turbines of 30-100MW range which is likely to grow multi-fold in the next 4-5 years. TTL is virtually a debt-free
company with a limited capex requirement and an efficient working capital cycle, reflected in very healthy return ratios. Further, boosted
by the expected uptick in the domestic capex cycle, the companys earnings are likely to grow by 25%+ per annum over the next 3-4
years.
V Guard Ind V-Guard Industries is an established brand in the electrical and household goods space, particularly in south India. Over the years, it has
successfully ramped up its operation and network to become a multi-product company. The company has a strong presence in the south
region. It is also aggressively expanding in non-south markets and is particularly focusing on the tier-II and III cities where there is a lot of
pent-up demand for its products.
Va Tech Wabag VA Tech Wabag (VTW) is one of the worlds leading companies in the water treatment field with eight decades of plant building experience.
Given the rising scarcity of fresh water availability, we expect flow of huge investments in water segment both globally and domestically.
With rising urbanisation and industrialisation in India, we expect substantial investments in this space. Given the large opportunity ahead
and inherent strengths of VTW, like professional management, niche technical expertise and global presence, we remain positive on the
stock.
Infrastructure/Real estate
Gayatri Proj Gayatri Projects is a Hyderabad-based infrastructure company with a very strong presence in irrigation, road and industrial construction
businesses. The order book stands at Rs12,510 crore, which is 6.9x its FY2016 revenues. It is also expanding its power and road BOT
portfolio and plans to unlock value by offloading stake to private equity. The company has potential to transform itself into a bigger entity.
IL&FS Trans IL&FS Transportation Networks is Indias largest player in the BOT road segment with a pan-India presence and a diverse project
portfolio. The fair mix of annuity and toll projects, and state and NHAI projects along with the geographical diversification across 12 states
reduce the risk to a large extent and provide comfort. Further, a strong pedigree along with the outsourcing of civil construction activity
helps it to scale up its portfolio faster. Thus, it is well equipped to capitalise on the huge and growing opportunity in the road infrastructure
sector.
IRB Infra IRB Infrastructure Developers is the largest toll road BOT player in India and the second largest BOT operator in the country with all its
projects being toll based. It has an integrated business model with an in-house construction arm which provides a competitive advantage
in bidding for the larger projects and captures the entire value from the BOT asset. Further, it has a profitable portfolio as majority of its
operational projects have become debt-free and it has presence in high-growth corridors which provides healthy cash flow. Thus, it is well
poised to benefit from the huge opportunity in the road development projects on the back of its proven execution capability and the scale
of its operations.
Jaiprakash Asso Jaiprakash Associates has been facing earnings pressure across business verticals. Further, it is in the process of concluding its cement
asset sale to deleverage its balance sheet. The construction and real estate division has also been underperforming lately. The current
uncertainty in business restructuring and liquidity concerns has led to a cautious view on the stock.
L&T Larsen & Toubro, being the largest engineering and construction company in India, is a direct beneficiary of the domestic infrastructure
capex cycle. Further, backed by its sound execution track record and healthy order book, the company will do well. Monetisation of the
non-core businesses will continue for some time, leaving scope for further value unlocking. Measures planned by the company to improve
its return ratios augur well. Hence, we remain positive on the stock.
NBCC NBCC (India), a Navratna public sector enterprise is notified as a Public Works Organization (PWO), which gives it a unique eligibility to
bag orders on a nominated basis from government departments and PSUs. NBCC has already amassed a huge order book, which gives
it a strong revenue visibility for the next five years. Moreover, future prospects look much brighter given the opportunities from multiple
areas, like redevelopment of old government colonies in Delhi, Rajasthan & Odisha, development of government lands, Smart Cities,
Housing for All 2022 and Amrut. Given the huge competitive advantage, a unique business model, high return ratios and healthy cash
flows, we remain positive on the stock.
Reliance Ind Reliance Industries has one of the largest and complex refining businesses in India which enjoys a substantially higher refining margin
over the benchmark GRM. Further, its petrochemical business is also highly efficient, where RIL is expanding capacity. We expect the
GRM to remain healthy and the petrochem margin to be maintained in the medium term on an uptick in the domestic demand is weighing
on the stock price; however, capex in downstream business (incremental capacity in the petchem business and petcoke gasification in
refining) would be the earnings driver in the coming years. Large investment in Reliance Jio could add value in long term.
Selan Exploration Selan Exploration Technology is an oil E&P company with five oil fields in the oil-rich Cambay Basin of Gujarat. The initiatives taken
to monetise the oil reserves in its Bakrol and Lohar oil fields are likely to improve production. Based on this, we expect it to ramp up
production significantly, subject to approval for the new wells. However, weak global oil prices are likely to be an overhang on the stock
in the medium term.
Pharmaceuticals
Aurobindo Pharma Aurobindo Pharma is set to post a healthy growth on the back of a ramp-up in the US and European markets, thanks to a strong product
pipeline built over a period and focus on niche segments like injectibles, hormones, penems and sterile products. The expected increase
in the export-led business and a favourable tilt in the revenue mix are likely to boost the margin, resulting in a faster growth in the earnings
as compared with the revenues. It has recently acquired the commercial operations (revenue size EUR320mn) of Actavis Plc in seven
western European countries and of Natrol in the USA to take on the nutraceutical business, which is a strategic fit.
Cadila A lot of key product approvals have been delayed due to regulatory issues at Cadilas Moraiya facility. The management confirmed that
the USFDA will re-inspect the Moraiya facility from February 6. We expect this inspection to go on for 3-5 days and the USFDA may give
its opinion post that. We feel that the uncertainty relating to the outcome of the USFDA inspection at Moraiya is likely to weigh on the stock
in the near term.
Cipla Cipla has brought about a paradigm shift in its business strategy. To revive growth, it has (1) enhanced focus on technology-intensive
products in the inhalation and nasal spray segments; (2) established front-end presence in the key markets like South Africa, USA and
Europe; (3) developed an appetite for inorganic expansions; and (4) invested in future growth areas like biosimilars. The UK approval for
gSeretide comes at a crucial time for Cipla, as it will help the company to gain traction in its business across global markets. The Cipla
management sounded confident of ramping up USA and EU businesses with new product launches, and expects benefits from cost-
control initiatives to drive the companys earnings from FY2018 onwards.
Divis Labs The US Food & Drug Administration (USFDA) inspected Divis Laboratories (Divis Lab) Unit-II at Visakhapatnam (Vizag) from November
29, 2016 to December 06, 2016. The USFDA has issued Form 483 with five observations, which are moderate to serious in nature. Divis
Labs Unit-II at Vishakhapatnam/Vizag is a very critical unit for the company, as majority of its exports are from this unit (around 50%+
sales come from this unit and even larger contribution to profitability). If the USFDAs 483 observation letter escalates to a Warning Letter
/ Import Alert, then it will impact the companys financials significantly, leading to a possible sharp downward revision in estimates.
Glenmark Pharma The management has given a revenue growth guidance of more than 25% for FY2017 (including Zetia). The company will report 12-15%
base revenue growth in FY2017 and FY2018 each. The management has indicated that for future growth, the key focus areas will be
dermatology, contraceptives and complex injectables. The growth would be mainly driven by the USA, EU and India, which are witnessing
an exponential growth on account of launch of new products. Currently, it has three new chemical entities and four new biological
entities in clinical trials, out-licensing potential. The gZetia launch scheduled in H2FY2017 will give a big fillip to the companys sales and
profitability, which should further help reduce debt on the companys balance sheet.
Lupin The expected ramp-up in the launch of oral contraceptives, ophthalmic products, branded franchise (with addition of in-licenced product-
Alinia, Inspira Chamber VHC and Locoid lotion) in the USA and a robust pipeline of new launches in the domestic and overseas markets
provide strong growth visibility for Lupin. Lupin has recently successfully closed its outstanding 483 letter at its key plant in Goa. Around
30 products are pending for USFDA approval from the Goa plant, which we expect to start soon. Delay in key product approvals, coupled
with growing competition and pricing pressure in the US business are increasing strain on the operating performance in the near term.
Sun Pharma The combination of Sun Pharma, Taro, Dusa Pharma, the generic business of URL Pharma and the acquisition of Ranbaxy offers
an excellent business model for Sun Pharma. Also, the integration process with Ranbaxy is set to help boost the profitability due to
favourable synergies from H2FY2017. The management maintains its aim to achieve a $300-mn synergy from the merger of Ranbaxy.
With a strong cash balance, it is well positioned to capitalise on the growth opportunities and inorganic initiatives. The company has
started receiving few approvals from the Halol unit, which points to resolution of the plant issues in the near future. Also, the Specialty
segment is expected to perform well, as the company has recently launched BromSite drug (used to treat Dry Eye disease). Also, very
recently, Sun Pharma launched Authorized Generics (AG) for Benicar, Benicar HCT, Azor and Tribenzor. All four products put together
recorded sales of $2.5 billion for the 12-month ended August 2016. Therefore, we expect Sun Pharmas H2FY2017 financial performance
to be positive and long-term performance to be solid.
Torrent Pharma Torrent Pharma is building a strong US pipeline, which could add ~30-40 products over FY2017-FY2019E. Improving market share in
Detrol and Nexium, additional product volumes from Dahej, and 10 new launches planned in FY2017 would partially mitigate the decline
in the companys US revenue during FY2017E. In the case of the India business, the Torrent Pharma management is focusing on
improving profitability by building larger brands in chronic diseases.
Building materials
Grasim Grasim is better placed compared with the other large players in the cement space due to its strong balance sheet, comfortable debt/
equity ratio, attractive valuation and diversified business. The full ramp-up of Vilayat plant (increasing capacity to 804,000 tonne) is likely
to aid VSF volumes going ahead, though prices may soften in the near term. Further, the merger of ABCIL and expansion in caustic
division are likely to maintain a strong performance in chemical division. On the cement front, the company expects demand to pick up in
the near term while a slow execution of government projects and surplus inventory remain concern areas.
The Ramco Cements The Ramco Cements, one of the most cost-efficient cement producers in India, will benefit from the capacity addition carried out ahead
of its peers in the southern region. In certain key markets of The Ramco Cements, like Telangana, Maharashtra and Andhra Pradesh,
demand has started to pick up but realisations have been under pressure. The company has reaped the benefits through cost-saving
measures, besides constantly reducing its debt, leading to improved profitability. In a nutshell, better volumes, cost efficiencies and
reducing leverage have yielded benefits for the company.
Shree Cement Shree Cements cement grinding capacity has grown to 27.2mtpa which will support its volume growth in the coming years. It has a power
plant with capacity of 612MW for its own consumption and merchant sale which is expected to support its revenue growth going ahead.
Thus, a volume growth of the cement division and the additional revenue accruing from the sale of surplus power will drive the earnings
of the company.
UltraTech Cement UltraTech Cement is Indias largest cement company with approximately 91mtpa cement capacity post acquisition of JP Associates
cement assets. The eastern region has seen a robust growth in infrastructure and housing demand while the other regions have seen
infrastructure spending only with no major improvement in housing and rural demand. The management has guided for a 7-8% demand
growth for FY17 driven by infrastructure spend and revival in retail demand after a good monsoon. However, the uncertainty over cement
price and increase in price of pet coke (trading with upward bias, Q3FY2017 onwards may feel the impact) will be the key monitorable
for FY17. However, cost efficiency (impact of new grinding and waste heat recovery) and base effect may lead to better operating
performance for UltraTech.
Discretionary consumption
Century Plyboards Century Plyboards is a leading player in the organised plywood industry with a market share of 25%. A strong growth in the sector,
Centurys premium positioning and brand equity strength, and the impending GST roll-out would enable it to post a revenue growth
(CAGR) of 18.1% over FY2016-FY2018E. On the back of a revenue growth and better absorption of fixed costs, the earnings are likely to
grow at a rate of 19.4% CAGR over FY2016-FY2018E. We believe that the structural growth story in terms of GST implementation and
capacity expansion benefits remains intact, but are still 6-9 months away. Therefore, we downgrade the stock to Hold with an unchanged
price target (PT) of Rs257.
Cox & Kings: Cox & Kings is an integrated player in the tourism & travel industry, with a strong presence in the global leisure travel segment and the
education tourism segment in Europe. It has a 30% market share in the global outbound tourism market. Demonetisation and GST
implementation are key positives for CKLs domestic Leisure Travel business from a long-term perspective due to the expected shift
from the unorganised players to organized ones. On the other hand, Education and Meininger business is expected to post a decent
performance in the coming years. Also, the management would reduce the consolidated debt by Rs400-500 crore per year through
internal cash flows. Therefore, we maintain our Buy recommendation with a revised price target of Rs225
Info Edge (India) Info Edge is Indias premier online classified company in the recruitment, matrimony, real estate, education and related service sectors.
Naukri is a quality play on the improving macro environment and is directly related to the GDP growth and Internet/mobile penetration.
Further, prevailing lower competitive intensity in the real estate space is positive in terms of profitability. We expect Zomato business
growth to extend in the coming years, with better integration of services and increasing monetisation opportunities. We continue to derive
comfort on Info-Edges business strength, with leading market share in key businesses. We expect its earnings trajectory to catch up, as
the macro headwinds subside.
INOX Leisure INOX Leisure Ltd (ILL), Indias second largest multiplex operator with 113 properties and 446 screens across 57 cities (accounting for
about 27% of the multiplex screens in India) is scripting a blockbuster growth story through a mix of inorganic and organic expansion plans
to scale up the total screen count to 890 screens over the next 24-30 months. The ILL mega show is supported by an improving content
quality in the Indian mainstream and regional cinema with its movies regularly hitting the Rs100-crore or Rs200-crore box-office collection
mark. We continue to remain positive on ILL from a long-term perspective, given its pan-India growth plans, healthy balance sheet (lower
financial leverage) and potential benefits from GST rollout.
KKCL Kewal Kiran Clothing is a branded apparel play with four brands in its kitty. Killer, its flagship denim brand, has created a niche space in
the minds of consumers. We expect KKCL to get back to double-digit revenue growth on the back of its strong brand equity and enhanced
distribution reach. KKCL has one of the best balance sheets among the Indian branded apparel players, with high return ratios and
positive free cash flows, which make it one of the better picks in the branded apparel space.
Orbit Exports Orbit Exports (Orbit) is a leading manufacturer and exporter of novelty fabrics exporting its products to over 32 countries. It is a recognised
star export house and operates in the niche area of high-end fancy fabrics, which are mainly used by designers in womens fashion
apparels. FY2017 can be considered as a year of consolidation for Orbit, with events such as slowdown in the Middle East, currency
devaluation in LatAm and demonetisation in India adversely affecting the companys performance in the near term. However, the Orbit
management is confident of recovery in FY2018, with a clear focus on growing the high-margin businesses. Also, Orbit has one of the
better balance sheets in the Textile industry and we expect it to improve further in the coming years. However, in view of near-term
concerns in the export markets, we downgrade our rating from Buy to Hold with price target under review.
Raymond Raymond is present in the fast-growing discretionary & lifestyle category of branded textiles and apparels. With growing incomes, rise
in aspirations to lead a luxurious life, greater discretionary spending and favourable demographics, the segment of branded apparels &
fabrics presents a good growth opportunity and Raymond with its brands and superior distribution set-up is very well geared to encash
the same. We expect recovery to take some more time, considering the slowdown in the overall discretionary consumer spending.
The company is focusing on strengthening brands, product innovation and expansion of distribution network (through an asset-light
model), and turning around its non-textile businesses. However, the result of these initiatives would take time to reflect in the operational
performance.
Relaxo Footwear Relaxo Footwear is present in the fast-growing footwear category, wherein it caters to customers with its four top-of-the-mind-recall
brands, viz, Hawaii, Sparx, Flite and Schoolmate. It has emerged as an attractive investment opportunity due to its growing scale,
strong brand positioning and healthy financial performance. Being mainly into the mass footwear segment, the revival of revenue after
the demonetisation effect would be faster for Relaxo compared to other footwear retail players. We expect the revival in the companys
sales to kick in from Q1FY2018. Also, the implementation of GST will bring under its fold all the unorganised players, and we believe that
the price difference between branded and unbranded players will get reduced.
Thomas Cook (I) Thomas Cook India (TCIL), owned by the legendary value investor Prem Watsa, is an integrated leisure travel and human service
management company in India. The improvement in the domestic and global macro environment provides a huge growth opportunity in
the Indian leisure and travel industry. The top management of TCIL has indicated that the Governments demonetisation drive will have
near-term impact on the performance of its Travel & Tourism business, as the bookings for summer holidays 2017 (Q1FY2018) will be
adversely impacted. However, TCILs management is confident of seeing a recovery in the Travel business in the next 6-8 months once
the macro-economic environment attains certain stability. We maintain Buy with a price target of Rs229.
Wonderla Holidays Wonderla Holidays Ltd (WHL) is the largest amusement park company in India with over a decade of successful and profitable operations.
It owns and operates two amusement parks under the brand name Wonderla in Kochi and Bengaluru, and came up with a third park
in Hyderabad in Q1FY2017. The company posted strong growth in footfalls in Q3FY2017 and we expect this trend to continue going
forward, as WHL endeavors to provide better entertainment services to its patrons at a reasonable price. The companys better cash
generation ability and a strong balance sheet make WHL one of the better plays in the consumer discretionary services space. Therefore,
we maintain our Buy recommendation with a revised price target of Rs 425.
Zee Entertainment Zee Entertainment Enterprises, part of the Essel group, is one of Indias leading TV media and entertainment companies. It has a
bouquet of more than 40 channels across Hindi, regional, sports and lifestyle genres. ZEEL continues to outperform the broadcasting
advertising market and expects to continue the momentum with an improvement in the macro economy. ZEELs recent move to exit from
the loss-making sports business will improve its profitability, strengthen balance sheet and position the company to accelerate inorganic
or strategic investments. We continue to see ZEEL as the prime beneficiary of macro revival and digitisation.
Diversified/Miscellaneous
Aditya Birla Nuvo We believe that the outlook for ABNLs Financial Services business remains bright, although the Manufacturing vertical continues to lag.
Further, Ideas profitability is likely to remain under pressure in the near term. Pre-amalgamation, we have revised our price target (PT)
for ABNL to Rs1,250 on account of de-rating of its Telecom business and subdued operating performance of its Manufacturing verticals.
We maintain our Hold rating on the stock.
Bajaj Holdings Bajaj Holdings & Investment Ltd (BHIL, erstwhile Bajaj Auto) was demerged in December 2007, whereby its manufacturing business
was transferred to the new Bajaj Auto Ltd (BAL) and its strategic business consisting of the wind farm and financial services businesses
was vested with Bajaj FinServ (BFS). All the businesses and properties, assets, investments and liabilities of erstwhile Bajaj Auto, other
than the manufacturing and strategic ones, now remain with BHIL. BHIL is a primary investment company focused on new business
opportunities. Given the strategic nature of BHILs investments (namely BAL and BFL), we have given a holding company discount of 50%
to BHILs equity investments. The liquid investments, and investments in other group companies have been valued at cost. Further, the
price target (PT) for BFS has been revised upwards to Rs3,890, as the company has reported better-than-expected results for Q2FY2017
and long-term upside potential remains intact since all three business streams are in high-growth and emerging segments. Consequently,
we have maintained our Buy rating and have revised the PT to Rs2,516.
Bharti Airtel Bharti Airtel is the leader in the Indian mobile telephony space. The long awaited entry of a competitor with deep pockets Reliance
Jio - in the market with aggressive pricing and deep market penetration strategy, Airtel will have to bear the brunt in the short term. Going
forward, from a long-term perspective, explosive growth in the data segment, strong network and reach will help Bharti emerge stronger,
but the near-term blips make us keep our Hold rating on the stock with a price target of Rs340.
BEL Bharat Electronics, a PSU manufacturing electronic, communication and defence equipment, stands to benefit from the enhanced
budgetary outlay for strengthening and modernising the countrys security. The Make in India initiative of the government will support
the earnings growth in the coming years, as it is the only player with strong research and manufacturing units across the country. The
companys current order book of around Rs33,806 crore provides revenue visibility for the next three to four years.
GDL With its dominant presence in the container freight station segment and recent forays into the rail freight and cold chain businesses,
Gateway Distriparks has evolved as an integrated logistic player. Its CFS business is a cash cow while its investments in the rail and cold
storage businesses have started bearing fruits. It is one of the largest players in the CFS business and has also evolved as the largest
player in the rail freight business as well as the cold storage business. The proposed capex for a.ll the three segments will strengthen its
presence in each of the segments and increase its pan-India presence.
Max India Max India has demerged into three different entities of which Max Financial Services will hold Max Life Insurance (new Max India will hold
Max Healthcare, Max Bupa Health Insurance and Antara businesses). Max Life Insurance (held by Max Financial Services) is among
the leading private sector insurers, has gained the critical mass and enjoys among the best operating parameters in the industry. As the
insurance sector is showing signs of stabilisation, the companys favourable product mix and a strong distribution channel will result in a
healthy growth in the premiums and profits.
PI Industries PI Industries (PII), a leading agro-chemical company, has a differentiated business model with focus on the fast-growing custom synthesis
and manufacturing (CSM) business, which contributes 60% of its revenues. To sustain the growth momentum, the company has expanded
its manufacturing capacity in Jambusar at a cost of Rs300 crore and the new capacity has commissioned in H2FY2016. PII is gradually
ramping up production at the recently commissioned Jambusar facility. The new products launched in the recent past have gained
good acceptability in the market and would continue to contribute to topline growth. We expect demand to be majorly unaffected due to
demonetisation, as outlook for the CSM business (exports), which accounts for ~60% of total sales, remains strong and unaffected. In the
domestic market, demand is likely to be impacted due to demonetisation, which could normalise by Q4FY2017. On the EBIDTA margin
front, PII has guided for 100-150BPS improvement on account of a richer product mix and likely improvement in operational efficiencies.
The companys order book stands at $800 million. PII has lined up a capex of ~Rs200 crore for FY2017 and ~Rs150 crore for FY2018.
Structurally, PII will benefit from its unmatched CSM capabilities (exports business), distribution reach and brand advantage in the
domestic markets. We have maintained our Buy rating on the stock with a revised PT of Rs955.
Ratnamani Metals Ratnamani Metals & Tubes is the largest stainless steel tube and pipe maker in India. Despite the challenging business environment
due to increasing competition, we remain positive on RMTL on the back of its strong balance sheet, the companys ability to generate
superior return ratios in the coming years and expansion of seamless SS tube capacity in the next few years. Further, the management
has maintained a strong outlook on the potential opportunities in the oil & gas sector and inter-connection of the rivers across the country.
Supreme Ind Supreme Industries is a leading manufacturer of plastic products with a significant presence across piping, packaging, industrial and
consumer segments. We remain positive on its new launches of value-added products and capacity expansion plans, which are largely
funded by its robust internal accruals. The company enjoys superior return ratios with low gearing levels. With diversified products,
extensive distribution network, improved capital structure and government thrusts on better infrastructure, Supreme has emerged as one
of the best proxy play on the increasing use of plastic consumption in India. Hence, we remain positive on the stock.
UPL UPL is a leading global producer of crop protection products, intermediates, specialty chemicals and other industrial chemicals, United
Phosphorus has presence across agricultural inputs segment ranging from seeds to crop protection products and post-harvest activities.
It has also started to focus on premium products in agro-chemicals. UPLs consistent focus and ability to introduce innovative products
(both in India and overseas markets), presence in high-growth markets (Brazil and India) and plans of tapping new markets augur well
for the company. Strong growth momentum in the Latin American markets, with the company aiming to outpace the industry growth and
gain market share, coupled with a favorable outlook for the Indian business will help UPL to boost its overall performance and achieve its
revenue growth target of 15%-20% for FY2017. Also, a better product mix, operating leverage and likelihood of market share gains in the
key markets should boost the overall performance. We retain our Buy rating with a revised Price Target (PT) of Rs 855.